Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances

Research in Autism Spectrum Disorders

Volumn 4, Issue 2, 2010, Pages 119-155

  Prandota, Joseph ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Autistic spectrum disorders; Cerebral toxoplasmosis; Depressed enzyme activities; Hypercytokinemia; Hypermetabolic state; Immune irregularities; Nitric oxide; Oxidative stress

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MEASLES MUMPS RUBELLA VACCINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RECOMBINANT ALPHA INTERFERON A; THEOPHYLLINE; THIOMERSAL; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ASTHMA; AUTISM; BACTERIAL INFECTION; CYTOKINE PRODUCTION; DRUG FATALITY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; ENVIRONMENTAL FACTOR; FEBRILE CONVULSION; GENETIC ASSOCIATION; HEPATITIS C; HUMAN; HYPERMETABOLISM; IMMUNOCOMPETENCE; IMMUNOMODULATION; LIPID PEROXIDATION; LYME DISEASE; NEPHROTIC SYNDROME; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PYELONEPHRITIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TOXOPLASMA GONDII; TOXOPLASMOSIS; URINARY TRACT DISEASE; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; WASTING SYNDROME; XENOBIOTIC METABOLISM;

EID: 73749087112     PISSN: 17509467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rasd.2009.09.011     Document Type: Review

References (578)

1. Abdel-Razzak Z., Corcos L., Fautrel A., Campion J.P., and Guillouzo A. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Molecular Pharmacology 46 (1994) 1100-1110
2. Abdel-Razzak Z., Corcos L., Fautrel A., and Guillouzo A. Interleukin-1 beta antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture. FEBS Letters 366 (1995) 159-164
3. Abdel-Razzak Z., Loyer P., Fautrel A., Gautier J.C., Corcos L., Turlin B., et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Molecular Pharmacology 44 (1993) 707-715
4. Aboagye-Mathiesen G., Toth F.D., Zdravkovic M., and Ebbesen P. Human trophoblast interferons: Production and possible roles in early pregnancy. Early Pregnancy 1 (1995) 41-53
5. Abou-Bacar A., Pfaff A.W., Georges S., Letscher-Bru V., Filisetti D., Villard O., et al. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infection and Immunity 72 (2004) 1397-1401
6. Adams J.B., and Holloway C. Pilot study of a moderate dose multivitami/mineral supplement for children with autistic spectrum disorder. Journal of Alternative and Complementary Medicine 10 (2004) 1033-1039
7. Adams L.B., Hibbs J.B., and Kranhebuhl J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from l-arginine. Journal of Immunology 144 (1990) 2725-2729
8. Adams M.L., Meyer E.R., Sewing B.N., and Cicero P.C. Effect of nitric oxide-related agents on rat testicular function. Journal of Pharmacology and Experimental Therapeutics 269 (1994) 230-237
9. Agarwal S.K., and Marshall Jr. G.D. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. Journal of Interferon and Cytokine Research 21 (2001) 147-155
10. Agrawal A., Kaushal P., Agrawal S., Gollapudi S., and Gupta S. Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. Journal of Leukocyte Biology 81 (2007) 474-482
11. Aldred S., Moore K.M., Fitzgerald M., and Waring R.H. Plasma amino acid levels in children with autism and their families. Journal of Autism Developmental Disorders 33 (2003) 93-97
12. Alexander J., Jebbari H., Bluethmann H., Brombacher F., and Roberts C.W. The role of IL-4 in adult acquired and congenital toxoplasmosis. International Journal of Parasitology 28 (1998) 113-120
13. Aliberti J. Host persistence: Exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nature Reviews: Immunology 5 (2005) 162-170
14. Alm B., Wennergren G., Norvenius S.G., Skjaerven R., Lagercrantz H., Helweg-Larsen K., et al. Vitamin A and sudden infant death syndrome in Scandinavia 1992-1995. Acta Paediatrica 92 (2003) 162-164
15. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 26 (2000) 76-80
16. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
17. Amin-Zaki L., Majeed M.A., Elhassani S.B., Clarkson T.W., Greenwood M.R., and Doherty R.A. Prenatal methylmercury poisoning. Clinical observations over five years. American Journal of Diseases of Children 133 (1979) 172-177
18. Anari M.R., Cribb A.E., and Renton K.W. The duration of induction and species influences the downregulation of cytochrome P450 by the interferon inducer polyinosinic acid-polycytidylic acid. Drug Metabolism and Disposition 23 (1995) 536-541
19. Andersson P.B., Perry V.H., and Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48 (1992) 169-186
20. Ansher S., Thompson W., Bridgewater J., and Snoy P. Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infection and Immunity 61 (1993) 4240-4247
21. Ansher S., Thompson W., Snoy P., and Habig W. Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine absorbed. Infection and Immunity 60 (1992) 3790-3798
22. Ansher S.S., and Thompson W. Modulation of hepatic mRNA levels after administration of lipopolysaccharide and diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP vaccine) to mice. Hepatology 20 (1994) 984-991
23. Araujo F.G., and Slifer T. Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice. Infection and Immunity 71 (2003) 4171-4174
24. Arita K., Kanno T., Takehara Y., Fujiwara T., Akiyama J., Horton A.A., et al. Effect of n-3 and n-6 polyunsaturated fatty acids and their ethylesters on stimuli-dependent superoxide generation in neutrophils. Physiological Chemistry and Physics and Medical NMR 33 (2001) 121-132
25. Armstrong S.G., and Renton K.W. Factors involved in the down-regulation of cytochrome P450 during Listeria monocytogenes infection. International Journal of Immunopharmacology 16 (1994) 747-754
26. Arnaud P., Gianazza E., and Miribel L. Ceruloplasmin. Methods in Enzymology 163 (1988) 441-452
27. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. International Journal of Developmental Neuroscience 23 (2005) 189-199
28. Arnold J.D., Hill G.N., and Sansom L.N. A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission. European Journal of Clinical Pharmacology 20 (1981) 443-447
29. Arsenijevic D., Bilbao F.D., Giannakopoulos P., Girardier L., Samec S., and Richard D. A role for interferon-gamma in the hypermetabolic response to murine toxoplasmosis. European Cytokine Network 12 (2001) 518-527
30. Arsenijevic D., Girardier L., Seydoux J., Chang H.R., and Dulloo A.G. Altered energy balance and cytokine expression in a murine model of chronic infection with Toxoplasma gondii. American Journal of Physiology 272 (1997) E908-E917
31. Arsenijevic D., Girardier L., Seydoux J., Pechere J.C., Garcia I., Lucas R., et al. Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection. American Journal of Physiology 274 (1998) E439-E445
32. Asensio C.S., Arsenijevic D., Lehr L., Giacobino J.P., Muzzin P., and Rohner-Jeanrenaud F. Effects of leptin on energy metabolism in beta-less mice. International Journal of Obesity (London) 32 (2008) 936-942
33. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., and Luhesi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: Implications for schizophrenia. Molecular Psychiatry 11 (2006) 47-55
34. Ashwood P., Anthony A., Torrente F., and Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. Journal of Clinical Immunology 24 (2004) 664-673
35. Asrankulova D.B., Rizopulu A.P., and Kurbanov D.D. Immune status and proinflammatory cytokines in pregnant wome with acute cytomegalovirus infection. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 4 (2004) 84-86
36. Astrup J., Rehcrona S., and Siesio B.K. The increase in extracellular potassium concentration in the ischemic brain in relation to preischemic functional activity and cerebral metabolic rate. Brain Research 199 (1980) 161-174
37. Atamer A., Bilici B., Yenice N., Selek S., Ilhan N., and Atamer Y. The importance of paraoxonase 1 activity, nitric oxide and lipid peroxidation in hepatosteatosis. Journal of International Medical Research 36 (2008) 771-776
38. Ausiello C.M., Urbani F., la Sala A., Lande R., and Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-c or acellular pertussis vaccines. Infection and Immunity 65 (1997) 2168-2174
39. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: Autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveillance Summary 56 (2007) 12-28
40. Autism Society of America. What is autism? (2009). http://www.autism-society.org/site/DocServer/WhatisAutism_R6.pdf%3FdocID =3681 Available at: www.autism-society.org/site/DocServer/WhatisAutism_R6.pdf?docID=3681
41. Aygun A.D., Gungor S., Ustundag B., Gurgoze M.K., and Sen Y. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators of Inflammation 3 (2005) 180-183
42. Bal-Price A., and Brown G.C. Nitric-oxide-induced necrosis and apoptosis in PTC12 cells mediated by mitochondria. Journal of Neurochemistry 75 (2000) 1455-1464
43. Baltaci A.K., Bediz C.S., Mogulkoc R., Kurtoglu E., and Pekel A. Effect of zinc and melatonin supplementation on cellular immunity in rats with toxoplasmosis. Biological Trace Element Research 96 (2003) 237-245
44. Barkin R.L., Schwer W.A., and Barkin S.J. Recognition and management of depression in primary care: A focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants. American Journal of Therapeutics 7 (1999) 205-226
45. Barna M., Komatsu T., and Reiss C.S. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223 (1996) 331-343
46. Baron-Cohen S. About 1% of children in the South Thames region have an autistic spectrum disorder. Evidence Based Mental Health 10 (2007) 28
47. Barosz G. Reactive oxygen species: Destroyers or messengers?. Biochemical Pharmacology 77 (2008) 1303-1315
48. Bartha A.I., Foster-Barber A., Miller S.P., Vigneron D.B., Glidden D.V., Barkovich A.J., et al. Neonatal encephalopathy: Association of cytokines with MR spectroscopy and outcome. Pediatric Research 56 (2004) 960-966
49. Baskin H., Ellermann-Eriksen S., Lovmand J., and Mogensen S. Herpes simplex virus type 2 synergizes with interferon-γ in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-α. Journal of General Virology 78 (1997) 195-203
50. Baskin D.S., Ngo H., and Didenko V.V. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicological Sciences 74 (2003) 361-368
51. Beale E.G., Hammer R.E., Antoine B., and Forest C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends in Endocrinology and Metabolism 15 (2004) 192
52. Beale E.G., Antoine B., and Forest C. Glyceroneogenesis in adipocytes: Another textbook case. Trends in Biochemical Sciences 28 (2003) 402-403
53. Beaman M.H., Hunter C.A., and Remington J.S. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-γ and TNF-α. Journal of Immunology 153 (1994) 4583-4587
54. Bell J.G., MacKinlay E.E., Dick J.R., MacDonald D.J., Boyle R.M., and Glen A.C. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids 71 (2004) 201-204
55. Bellocq A., Azoulay E., Marullo S., Flahault A., Fouqueray B., Philippe C., et al. Reactive oxygen and nitrogen intermediates increase transforming growth factor-β1 release from human epithelial alveolar cells through two different mechanisms. American Journal of Respiratory Cell and Molecular Biology 21 (1999) 128-136
56. Belo L., Santos-Silva A., Rocha S., Ioshii S.O., Domanski A.C., Kfouri D., et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. European Journal of Obstetrics and Reproductive Biology 123 (2005) 46-51
57. Benedetto N., Folgore A., Romano-Carratelli C., and Galdiero F. Effects of cytokines and prolactin on the replication of Toxoplasma gondii in murine microglia. European Cytokine Network 12 (2001) 348-358
58. Benzecry, J. M., Deth, R., & Holtzman, D. (in press). Abnormalities in respiratory properties of lymphoblasts in autistic spectrum disorders. United Mitochondrial Disease Foundation Abstracts.
59. Berkow R.L., Wang D., Larrick J.W., Dodson R.W., and Howard T.H. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. Journal of Immunology 139 (1987) 3783-3791
60. Bernard S., Enayati A., Redwood L., Roger H., and Binstock T. Autism: A novel form of mercury poisoning. Medical Hypotheses 56 (2001) 462-471
61. Bernassola F., Rossi A., and Melino G. Regulation of transglutaminases by nitric oxide. Annals of New York Academy of Sciences 887 (1999) 83-91
62. Bertini R., Bianchi M., Villa P., and Ghezzi P. Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: A comparison with lymphotoxin and interferon. International Journal of Immunopharmacology 10 (1988) 525-530
63. Bhopale G.M. Pathogenesis of toxoplasmosis. Comparative Immunology Microbiology and Infectious Diseases 26 (2003) 213-222
64. Bikjdaouene L., Escames G., Leon J., Ferrer J.M., Khaldy H., Vives F., et al. Changes in brain aminoacids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures. Journal of Pineal Research 35 (2003) 54-60
65. Bliss S.K., Marshall A.J., Zhang Y., and Denkers E.Y. Human polymorphonuclear leukocytes produce IL-12, TNF-α and the chemokines macrophage-inflammatory protein-1α and -1β in response to Toxoplasma gondii antigens. Journal of Immunology 162 (1999) 7369-7375
66. Blood-Siegfried J., Crabb Breen E., Takeshita S., and Martinez-Maza O. Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components. Journal of Clinical Immunology 18 (1998) 81-88
67. Bohne W., Heesemann J., and Gross U. Reduced replication of Toxoplasma gondii is necessary for identification of bradyzoite specific antigens: A possible role for nitric oxide in triggering stage conversion. Infection and Immunity 62 (1994) 1761-1767
68. Bölte S., Ozkara N., and Poustka F. Autism spectrum disorders and low body weight: Is there really a systematic association?. International Journal of Eating Disorders 31 (2002) 349-351
69. Borecky L., and Lackovic V. Partial heterologus tolerance to interferon production in mice infected with B. pertussis. Acta Virologica 10 (1966) 271-272
70. Borutaite V., and Brown G.C. Rapid reduction of NO by mitochondria, and reversible inhibition of mitochondrial respiration by NO. Biochemistry Journal 315 (1996) 295-299
71. Bottini N., De Luca D., Saccucci P., Fiumara A., Elia M., Porfirio M.C., et al. Autism: Evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics 3 (2001) 111-113
72. Bowie W.R., King A.S., Werker D.H., Isaac-Renton J.L., Eng S.B., and Marion S.A. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma investigation Team. Lancet 350 (1997) 173-177
73. Boyer K., Marcinak J., and McLeod R. Toxoplasma gondii (Toxoplasmosis). In: Long S., Pickering L.K., and Prober C.G. (Eds). Principles and practice of pediatric infectious disease. 3rd ed. (2007), Churchill Livingstone, New York
74. Bransfield R.C., Wulfman J.S., Harvey W.T., and Usman A.I. The association between tick-born infections, Lyme borreliosis and autism spectrum disorders. Medical Hypotheses 70 (2008) 967-974
75. Briggs W.A., Gao Z.H., Xing J.J., Gimenez L.F., Samaniego M.D., Scheel P.J., et al. Suppression of lymphocyte interleukin-2 receptor expression by glucocorticoids, cyclosporine, or both. Journal of Clinical Pharmacology 10 (1996) 931-937
76. Brown G.C. Nitric oxide and mitochondrial respiration. Biochimica and Biophysica Acta 1411 (1999) 351-369
77. Brown G.C., and Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochemical Society Symposium 66 (1999) 17-25
78. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochimica et Biophysica Acta 1504 (2001) 46-57
79. Bryson S., and Smith I. Epidemiology of autism: Prevalence, associated characteristics, and implications for research and service delivery. Mental Retardation and Developmental Disabilities Research Reviews 4 (1998) 97-103
80. Butcher B.A., and Denkers E.Y. Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infection and Immunity 70 (2002) 5216-5224
81. Butcher B.A., Greene R.I., Henry S.C., Annecharico K.L., Weinberg J.B., Denkers E.Y., et al. p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infection and Immunity 73 (2005) 3278-3286
82. Butcher B.A., Kim L., Johnson P.F., and Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. Journal of Immunology 167 (2001) 2193-2201
83. Butler M.A., Iwasaki M., Guengerich F.P., and Kadlubar F.F. Human cytochrome P450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences of the United States of America 86 (1989) 7696-7700
84. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatric Research 47 (2000) 64-72
85. Camarillo C., Kumar L.S., Bake S., Sohrabji F., and Miranda R.C. Ethanol regulates angiogenic cytokines during neural development: Evidence from an in vitro model of mitogen-withdrawal-induced cerebral cortical neuroepithelial differentiation. Alcoholism, Clinical and Experimental Research 31 (2007) 324-335
86. CDC. (2005). http://www.medicalhomeinfo.org/health/Autism%20downloads/AutismAlarm.pdf .
87. Cerami A., Ikeda Y., Le Trang N., Hotez P.J., and Beutler B. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: The role of cachectin (tumor necrosis factor). Immunology Letters 11 (1985) 173-177
88. Chance B. Catalases and peroxidases, part II. Methods of Biochemical Analysis 1 (1954) 408-424
89. Chang K.C., Bell T.D., Lauer B.A., and Chai H. Altered theophylline pharmacokinetics during acute respiratory viral ilness. Lancet 1 (1978) 1132-1133
90. Chao C.C., Anderson W.R., Hu S., Martella A., Gekker G., and Peterson P.K. Activated microglia inhibit Toxoplasma gondii via a nitric oxide mechanism. Clinical Immunology and Immunopathology 67 (1993) 178-183
91. Chao C.C., Gekker G., Hu S., and Peterson P.K. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. Journal of Immunology 152 (1994) 1246-1252
92. Chao C.C., Hu S., Gekker G., Novick Jr. W.J., Remington J.S., and Peterson P.K. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. Journal of Immunology 150 (1993) 3404-3410
93. Chauhan A., Chauhan V., Brown W.T., and Cohen I. Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferring-The antioxidant proteins. Life Sciences 75 (2004) 2539-2549
94. Chauhan A., Chauhan V., and Cohen I. Increased serum complement C3 and C4 levels in autism: A correlation with severity and language disability. FEBS Journal 272 Suppl. 1 (2005) 492
95. Chauhan A., and Chauhan V. Oxidative stress in autism. Pathophysiology 13 (2006) 171-181
96. Chauhan A., Mehta P.D., Cohen I.L., Barshatzky M., Brown W.T., and Chauhan V. Increased serum complement C3/C4 and alpha1-antichymotrypsin levels in autism. Proceedings of the 5th International meeting for autism research (IMFAR). Montreal, Canada (2006, June 1-3)
97. Chen J.Q., Strom A., Gustafsson J.A., and Morgan E.T. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Molecular Pharmacology 47 (1995) 940-947
98. Chen Y.-J., Jiang H., and Quilley J. The nitric oxide- and prostaglandin-independent component of the renal vasodilator effect of thimerosal is mediated by epoxyeicosatrienoic acids. Journal of Pharmacology and Experimental Therapeutics 304 (2003) 1292-1298
99. Chess S., Fernandez P., and Korn S. Behavioral consequences of congenital rubella. Journal of Pediatrics 93 (1978) 699-703
100. Chess S., and Fernandez P. Neurologic damage and behavior disorder in rubella children. American Annals of the Deaf 125 (1980) 998-1001
101. Chess S. Autism in children with congenital rubella. Journal of Autism and Childhood Schizophrenia 1 (1971) 33-47
102. Chess S. Follow-up report on autism in congenital rubella. Journal of Autism and Childhood Schizophrenia 7 (1977) 69-81
103. Chez M.G., Dowling T., Patel P.B., Khanna P., and Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatric Neurology 36 (2007) 361-365
104. Christ B., Nath A., Heinrich P.C., and Jungerman K. Inhibition by recombinant human interleukin-6 of the glucagon-dependent induction of phosphoenolpyruvate carboxykinase and the insulin-dependent induction of glucokinase gene expression in cultured rat hepatocytes: Regulation of gene transcription and messenger RNA degradation. Hepatology 20 (1994) 1577-1583
105. Christ B., Yazici E., and Nath A. Phosphatidylinositol 3-kinase and protein kinase C contribute to inhibition by interleukin 6 of phosphoenolpyruvate carboxykinase gene expression in cultured rat hepatocytes. Hepatology 31 (2000) 461-468
106. Christianson A.L., Chesler N., and Kromberg J.R.G. Fetal valproate syndrome: Clinical and neurodevelopmental features in two sibling pairs. Developmental Medicine and Childhood Neurology 36 (1994) 357-369
107. Corssmit E.P., Heijligenberg R., Endert E., Ackermans M.T., Sauerwein H.P., and Romijn J.A. Endocrine and metabolic effects of interferon-alpha in humans. Journal of Clinical Endocrinology and Metabolism 81 (1996) 3265-3269
108. Coppi G. Neuroprotective activity of alpha-dihydroergocryptine in animal models. Journal of Neural Transmission Suppl. 45 (1995) 307-318
109. Corbett B.A., Kantor A.B., Schulman H., Walker W.L., Lit L., Ashwood P., et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Molecular Psychiatry 12 (2007) 292-306
110. Correira C., Coutinho A., Diogo L., Grazinha M., Marques C., Miguel T., et al. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: No association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders 36 (2006) 1137-1140
111. Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., and Ojcius D.M. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. Journal of Biological Chemistry 282 (2007) 2871-2879
112. Curtin C., Bandini L.G., Perrin E.C., Tybor D.J., and Must A. Prevalence of overweight in children and adolescence with attention deficit hyperactivity disorder and autism spectrum disorders: A chart review. BMC Pediatrics 5 (2005) 48
113. D'Amello M., Ricci I., Sacco R., Liu X., D'Agruma L., Muscarella L.A., et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: Possible regional specificity in gene-environment interactions. Molecular Psychiatry 10 (2005) 1006-1016
114. Das S.K., Varadhan S., Gupta G., Mukherjee S., Dhanya L., Rao D.N., et al. Time-dependent effects of ethanol on blood oxidative stress parameters and cytokines. Indian Journal of Biochemistry and Biophysics 46 (2009) 116-121
115. Daubener W., Pilz K., Zennati S.S., Bilzer T., Fischer H.G., and Hadding U. Induction of toxoplasmosis in a human glioblastoma by interferon γ. Journal of Neuroimmunology 43 (1993) 31-38
116. Daubener W.C., Remscheid L., Nockemann S., Pilz K., Sghrouchni S., Mackenzie C., et al. Anti-parasitic effector mechanisms in human brain tumor cells: Role of interferon γ and tumor necrosis factor α. European Journal of Immunology 26 (1996) 487-492
117. Davies M.H., Ngong J.M., Yucesoy M., Acharya S.K., Mills C.O., Weaver J.B., et al. The adverse influence of pregnancy upon sulphation: A clue to the pathogenesis of intrahepatic cholestasis of pregnancy. Journal of Hepatology 21 (1994) 1127-1134
118. De Albuquerque M.C., Aleixo A.L., Benchimol E.I., Leandro A.C., das Neves L.B., Vicente R.T., et al. The IFN-gamma +874/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Memorias do Instituto Oswaldo Cruz 104 (2009) 451-455
119. De Clercq E., Nuwer M.R., and Merigan T.C. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. Journal of Clinical Investigation 49 (1970) 1565-1577
120. De Metz J., Sprangers F., Endert E., Ackermans M.T., ten Berge I.J., Sauerwein H.P., et al. Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans. Journal of Applied Physiology 86 (1999) 517-522
121. De Waziers I., Garlatti M., Bouguet J., Beaune P.H., and Barouki R. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell lines. Molecular Pharmacology 47 (1995) 474-479
122. De Wildt S.N., Kearns G.L., Leeder J.S., and van den Anker J.N. Cytochrome P450 3A: Ontogeny and drug disposition. Clinical Pharmacokinetics 37 (1999) 485-505
123. Deckert-Schluter M., Albrecht S., Hof H., Wiestler O.D., and Schluter D. Dynamics of the intracerebral and splenic cytokine mRNA production in Toxoplasma gondii-resistant and -susceptible congenital strains of mice. Immunology 85 (1995) 408-418
124. Del Punta K., Charreau E.H., and Pignataro O.P. Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 137 (1996) 5337-5343
125. Delaporte E., and Renton K.W. Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction. Life Sciences 60 (1997) 787-796
126. DeLong G.R., Bean S.C., and Brown III F.R. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Archives of Neurology 38 (1981) 191-194
127. Deloria L., Abbott V., Gooderham N., and Mannering G.J. Induction of xanthine oxidase and depression of cytochrome P-450 by interferon inducers: Genetic difference in the responses of mice. Biochemistry and Biophysics Research Communications 131 (1985) 109-114
128. Dengler T.J., Raftery M.J., Werle M., Zimmermann R., and Schönrich G. Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Transplantation 69 (2000) 1160-1168
129. Denkers E.Y., Butcher B.A., Del Rio L., and Kim L. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signalling cascades during intracellular Toxoplasma gondii infection. Immunology Reviews 201 (2004) 191-205
130. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11 (1998) 569-588
131. Derouich-Guergour D., Aldebert D., Vigan I., Jouvin-Marche E., Marche P.N., Aubert D., et al. Toxoplasma gondii infection can regulate the expression of tumour necrosis factor-alpha receptors on human cells in vitro. Parasite Immunology 24 (2002) 271-279
132. Dhiman N., Ovsiyannikova I.G., Ryan J.E., Jacobson R.M., Vierkant R.A., Pankratz V.S., et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clinical and Experimental Immunology 142 (2005) 498-504
133. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphism in cytokine and cytokine receptor genes. Journal of Infectious Diseases 195 (2007) 21-29
134. Dimier I.H., and Bout D.T. Inhibitory effect of interferon-gamma activated ovine umbilical vein endothelial cells on the intracellular replication of Toxoplasma gondii. Veterinary Research 27 (1996) 527-534
135. Donato M.T., Gomez-Lechon M.J., Jover R., Nakamura T., and Castell J.V. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics 284 (1998) 760-767
136. Döskaya M., Degirmenci A., Cicek C., Ak M., Korkmaz M., Gürüz Y., et al. Behavior of Toxoplasma gondii RH Ankara strain tachyzoites during continuous production in various cell lines. Parasitology 132 (2006) 315-319
137. Duclos P., and Ward B.J. Measles vaccines: A review of adverse events. Drug Safety 19 (1998) 435-454
138. Durkin M.S., Maenner M.J., Newschaffer C.J., Lee L.-C., Cunliff C.M., Daniels J.L., et al. Advanced parental age and the risk of autism spectrum disorder. American Journal of Epidemiology 168 (2008) 1268-1276
139. Echizen H., Ohta Y., Shirataki H., Tsukamoto K., Umeda N., Oda T., et al. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis. Journal of Clinical Pharmacology 30 (1990) 562-567
140. El Azhary R., and Mannering G.J. Effects of interferon inducing agents (polyriboinosinic acid. polyribocytidylic acid, tilorone) on hepatic hemoproteins (cytochrome P-450, catalase, tryptophan 2,3-dioxygenase, mitochondrial cytochromes), heme metabolism and cytochrome P-450-linked monooxygenase systems. Molecular Pharmacology 15 (1979) 698-707
141. El-Kadi A.O., Bleau A.M., Dumont I., Maurice H., and du Souich P. Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction. Drug Metabolism and Disposition 28 (2000) 1112-1120
142. Elkahwaji J., Robin M.A., Berson A., Tinel M., Letteron P., Labbe G., et al. Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochemical Pharmacology 57 (1999) 951-954
143. Ellermann-Eriksen S. Macrophages and cytokines in the early defence against herpes simplex virus. Virology Journal 2 (2005) 59
144. Evans R.D., Argiles J.M., and Williamson D.H. Metabolic effects of tumour necrosis factor-alpha (cachectin) and interleukin-1. Clinical Sciences 77 (1989) 357-364
145. Faas M.M., Bouman A., Veenstra van Nieuwenhoven A.L., van der Schaaf G., Moes H., Heineman M.J., et al. Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat. Journal of Leukocyte Biology 78 (2005) 946-953
146. Faber S., Zinn G.M., Kern II J.C., and Kingston H.M. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14 (2009) 171-180
147. Falus A., Biro J., and Rakasz E. Cytokine networks and corticosteroid receptors. Annals of New York Academy of Sciences 762 (1995) 71-77
148. Fantuzzi G., Sironi M., Delgado R., Cantoni L., Rizzardini M., Carelli M., et al. Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: Role of Bordetella pertussis cells in toxicity. Infection and Immunity 62 (1994) 29-32
149. Farid A.S., Nakahara K., Murakami N., Hayashi T., and Horii Y. Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats. American Journal of Tropical Medicine and Hygiene 78 (2008) 770-776
150. Farquhar D., Loo T.L., Gutterman J.U., Hersh E.M., and Luna M.A. Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guerin treatment. Biochemical Pharmacology 25 (1978) 1529-1535
151. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., et al. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Molecular Psychiatry 7 (2002) 633-640
152. Filipek P.A., Juranek J., Nguyen M.T., Cummings C., and Gargus J.J. Relative carnitine deficiency in autism. Journal of Autism and Developmental Disorders 34 (2004) 615-623
153. Filisetti D., and Candolfi E. Immune response to Toxoplasma gondii. Annali dell'Istituto Superiore di Sanita 40 (2004) 71-80
154. Fischer H.G., Nitzgen B., Reichmann G., and Hadding U. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. European Journal of Immunology 27 (1997) 1539-1548
155. Flegr J., Kodym P., and Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biological Psychology 53 (2000) 57-68
156. Flegr J., Preiss M., Klose J., Havlicek J., Vitakova M., and Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxoplasmosis?. Biological Psychology 63 (2003) 253-268
157. Floersheim G.L., and Szeszak J.J. PolymI-poly C and endotoxins share immunosuppressive properties and increase the toxicity of alpha-amanitin and hexobarbital. Agents and Actions 2 (1971) 150-155
158. Fombonne E. Are measles infections or measles immunizations linked to autism?. Journal of Autism and Developmental Disorders 29 (1999) 349-350
159. Forest C., Tordjman J., Glorian M., Duplus E., Chauvet G., Quette J., et al. Fatty acid recycling in adipocytes: A role for glyceroneogenesis and phosphoenolpyruvate carboxykinase. Biochemical Society Transactions 31 (2003) 1125-1129
160. Franko T.G., Powell D.A., and Nahata M.C. Pharmacokinetics of theophylline in infants with bronchiolitis. European Journal of Clinical Pharmacology 23 (1982) 123-127
161. Fujigaki S., Saito K., Takemura M., Maekawa N., Yamada Y., Wada H., et al. l-Tryptofan-l-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection in gamma interferon-gene-deficient mice: Cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infection and Immunity 70 (2002) 779-786
162. Gallowitsch-Puerta M., and Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sciences 80 (2007) 2325-2329
163. Garcia Del Busto Cano E., and Renton K.W. Modulation of hepatic cytochrome P450 during Listeria monocytogenes infection of the brain. Journal of Pharmaceutical Sciences 92 (2003) 1860-1868
164. Garin E.H., Laflam P., and Chandler L. Anti-interleukin 8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatric Nephrology 12 (1998) 381-385
165. Garner B., Baoutina A., Dean R.T., and Jessup W. Regulation of serum induced lipid accumulation in human monocyte derived macrophages by interferon gamma. Correlations with alipoprotein E production, lipoprotein lipase activity and LDL receptor related protein expression. Atherosclerosis 128 (1997) 47-58
166. Gavrilescu L.C., and Denkers E.Y. IFN-γ overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. Journal of Immunology 167 (2001) 902-909
167. Gazzinelli R.T., Eltoum I., Wynn T.A., and Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. Journal of Immunology 151 (1993) 3672-3681
168. Gazzinelli R.T., Amichay D., Scharton-Kersten T., Grunwald E., Farber J.M., and Sher A. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. In: Gross U. (Ed). Toxoplasma gondii. Current topics on microbiology and immunology Vol. 219 (1996), Springer, Berlin/Heidelberg/New York 127-139
169. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent upon CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. Journal of Immunology 157 (1996) 798-805
170. Gerber J.S., and Offit P.A. Vaccines and autism: A tale of shifting hypotheses. Clinical Infectious Diseases 48 (2009) 456-461
171. Gergel D., Misik V., Riesz P., and Cederbaum A.I. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Archives of Biochemistry and Biophysics 337 (1997) 239-250
172. Ghaziuddin M., Tsai L.Y., Eilers L., and Ghaziuddin N. Brief report: Autism and herpes simplex encephalitis. Journal of Autism and Develeopmental Diseases 22 (1992) 107-113
173. Ghezzi P., Bianchi M., Gianera L., Landolfo S., and Salmona M. Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Research 45 (1985) 3444-3447
174. Ghoshal S., Pasham S., Odom D.P., Furr H.C., and McGrane M.M. Vitamin A depletion is associated with low phosphoenolpyruvate carboxykinase mRNA levels during late fetal development and at birth in mce. Journal of Nutrition 133 (2003) 2131-2136
175. Gillberg C., and Wing L. Autism: Not an extremely rare disorder. Acta Psychiatrica Scandinavica 99 (1999) 399-406
176. Gillberg C. Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. Journal of Autism Developmental Disorders 16 (1986) 369-375
177. Gillberg I.C. Autistic syndrome with onset at age 31 years: Herpes encephalitis as a possible model for childhood autism. Developmental Medicine and Child Neurology 33 (1991) 920-924
178. Gillespie M.N., Owasoyo J.O., Kojima S., and Jay M. Enhanced chemotaxis and superoxide anion production by polymorphonuclear leukocytes from nicotine-treated and smoke-exposed rats. Toxicology 45 (1987) 45-52
179. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. Journal of Neuroimmunology 159 (2005) 106-112
180. Golan H.M., Lev V., Hallak M., Sorokin Y., and Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48 (2005) 903-917
181. Gomez Marin J.E., Pinon J.M., Bonhomme A., and Guenounou M. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines?. Medical Hypotheses 48 (1997) 161-169
182. Gonzales F., and Idle J. Pharmacogenetic phenotyping and genotyping: Present status and future potential. Clinical Pharmacokinetics 26 (1994) 59-70
183. Goodrum L.A., Saade G.R., Belfort M.A., Moise Jr. K.J., and Jahoor F. Arginine flux and nitric oxide production during human pregnancy and postpartum. Journal of the Society for Gynecologic Investigation 10 (2003) 400-405
184. Gorodischer R., Krasner J., McDevitt J.J., Nolan J.P., and Yaffe S.J. Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochemical Pharmacology 25 (1976) 351-353
185. Gosselin J., Flamand L., D'Addario M., Hiscott J., Stefanescu I., Ablashi D.V., et al. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. Journal of Immunology 149 (1992) 181-187
186. Gottschall P.E., Komaki G., and Arimura A. Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Neuroendocrinology 56 (1992) 935-938
187. Greenbaum R., Nulman I., Rovet J., and Koren G. The Toronto experience in diagnosing alcohol-related neurodevelopmental disorder: A unique profile of deficits and assets. Canadian Journal of Clinical Pharmacology 9 (2002) 215-225
188. Gross U., Kempf M.C., Seeber F., Lüder C.G., Lugert R., and Bohne W. Reactivation of chronic toxoplasmosis: Is there a link to strain-specific differences in the parasite?. Behring Institute Mitteilungen 99 (1997) 97-106
189. Halonen S.K., Chiu F.C., and Weiss L.M. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infection and Immunity 66 (1998) 4989-4993
190. Halonen S.K., Lyman W.D., and Chiu F.C. Growth and development of Toxoplasma gondii in human neurons and astrocytes. Journal of Neuropathology and Experimental Neurology 55 (1996) 1150-1156
191. Halonen S.K., Taylor G.A., and Weiss L.M. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infection and Immunity 69 (2001) 5573-5576
192. Halwachs-Baumann G., Weihrauch G., Gruber H.J., Desoye G., and Sinzger C. hCMV induced IL-6 release in trophoblast and trophoblast like cells. Journal of Clinical Virology 37 (2006) 91-97
193. 2 and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide: Biology and Chemistry 5 (2001) 504-513
194. Hansen R.A., Gartlehner G., Powell G.E., and Sandler R.S. Serious adverse events with infliximab: Analysis of spontaneously reported adverse events. Clinical Gastroenterology and Hepatology 5 (2007) 729-735
195. Hardan A.Y., and Handen B.L. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. Journal of Child and Adolescent Psychopharmacology 12 (2002) 237-241
196. Harder D.R., Lange A.R., Gebremdhin D., Birks E.K., and Roman R.J. Cytochrome P450 metabolites of arachidonic acid as intracellular signalling molecules in vascular tissue. Journal of Vascular Research 34 (1997) 237-243
197. Harris S.R., MacKay L.L., and Osborn J.A. Autistic behaviors in offspring of mothers abusing alcohol and other drugs: A series of case reports. Alcoholism, Clinical and Experimental Research 19 (1995) 660-665
198. Hassan J., Dooley S., and Hall W. Immunological response to cytomegalovirus in congenitally infected neonates. Clinical and Experimental Immunology 147 (2007) 465-471
199. Heaton M.B., Madorsky I., Paiva M., and Mayer J. Influence of ethanol on neonatal cerebellum of BDNF gene-deleted animals: Analyses of effects on Purkinje cells, apoptosis-related proteins, and endogenous antioxidants. Journal of Neurobiology 51 (2002) 160-176
200. Heaton M.B., Paiva M., Mayer J., and Miller R. Ethanol-mediated generation of reactive oxygen species in developing rat cerebellum. Neuroscience Letters 334 (2002) 83-86
201. Hebebrand J., Hennighausen K., Nau S., Himmelmann G.W., Schulz E., Schäfer H., et al. Low body weight in male children and adolescents with schizoid personality disorder or Asperger's disorder. Acta Psychiatrica Scandinavica 96 (1997) 64-67
202. Hermes G., Ajioka J.W., Kelly K.A., Mui E., Roberts F., Kasza K., et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. Journal of Neuroinflammation 5 (2008) 48
203. Hibbs J.G., Taintor R.R., Vavrin Z., and Rachlin E.M. Nitric oxide: A cytotoxin activated macrophage effector molecule. Biochemistry and Biophysics Research Communications 157 (1988) 87-94
204. Hill M., and McCallum R. Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. Journal of Clinical Investigation 88 (1991) 811-816
205. Hill M.R., and McCallum R.E. Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infection and Immunity 60 (1992) 4040-4050
206. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., et al. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. European Cytokine Network 17 (2006) 196-201
207. Hindley S., Juurlink B.H.J., Gysbers J.W., Middlemiss P.J., Herman M.A.R., and Rathbone M.P. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. Journal of Neuroscience 47 (1997) 427-439
208. Hojo H., and Hashimoto Y. Inhibition of drug metabolizing enzymes in the mouse after treatment with host-mediated antitoumor drugs. Toxicology Letters 1 (1977) 89-93
209. Hölscher C., and Rose S.P. An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neuroscience Letters 145 (1992) 165-167
210. Holtzman D. Autistic spectrum disorders and mitochondrial encephalopathies. Acta Paediatrica 97 (2008) 859-860
211. Hommes M.J.T., Romijn J.A., Endert E., and Sauerwein H.P. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. American Journal of Clinical Nutrition 54 (1991) 311-315
212. Horton A.A., and Fairhurst S. Lipid peroxidation and mechanisms of toxicity. Critical Reviews in Toxicology 18 (1987) 27-79
213. Hughes J.R. A review of recent reports on autism: 1000 studies published in 2007. Epilepsy and Behavior 13 (2008) 425-437
214. Hukkanen V., Broberg E., Salmi A., and Eralinna J.P. Cytokines in experimental herpes simplex virus infection. International Reviews of Immunology 21 (2002) 355-371
215. Hunter C.A., Litton M.J., Remington J.S., and Abrams J.S. Immunochemical detection of cytokines in the lymph nodes and brain of mice resistant or susceptible to toxoplasmic encephalitis. Journal of Infectious Diseases 170 (1994) 939-945
216. Hunter C.A., and Remington J.S. Immunopathogenesis of toxoplasmic encephalitis. Journal of Infectious Diseases 170 (1994) 1057-1067
217. Hunter C.A., Roberts C.W., Murray M., and Alexander J. Kinetics cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. European Journal of Immunology 22 (1992) 2317-2322
218. Israelski D.M., and Remington J.S. Toxoplasmosis in non-AIDS immunocompromised host. Current Opinion in Tropical Infectious Diseases 13 (1993) 322-356
219. Ivarsson S.A., Bjerre I., Vegfors P., and Ahlfors K. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21 (1990) 102-103
220. Jablonska E., and Marcinczyk M. TRL2 expression in relation to IL-6 and IL-1β and their natural regulators production by PMN and PBMC in patients with Lyme disease. Mediators of Inflammation, article ID 32071 (2006) 1-6
221. Jaffe C.A., Ocampo-Lim B., Guo W., Krueger K., Sugahara I., DeMott-Friberg R., et al. Regulatory mechanisms of growth hormone secretion are sexually dimorphic. Journal of Clinical Investigation 102 (1998) 153-164
222. Jaffe C.A., Turgeon D.K., Lown K., DeMott-Friberg R., and Watkins P.B. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. American Journal of Physiology Endocrinology and Metabolism 283 (2002) E1008-E1015
223. Jain S.K. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. Journal of Biological Chemistry 259 (1984) 3391-3394
224. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., et al. Metabolic biomarkers of increased metabolic stress and impaired methylation capacity in children with autism. American Journal of Clinical Nutrition 80 (2004) 1611-1617
225. Jay M., Kojima S., and Gillespie M.N. Nicotine potentiates superoxide anion generation by human neutrophils. Toxicology and Applied Pharmacology 86 (1986) 484-487
226. Jeong H.J., Hong S.H., Park R.K., An N.H., and Kim H.M. Ethanol induces the production of cytokines via the Ca2+, MAP kinase, HIF-1alpha, and NF-kappaB pathway. Life Sciences 77 (2005) 2179-2192
227. Jersmann H.P., Rathjen D.A., and Ferrante A. Enhancement of lipopolysaccharide-induced neutrophil oxygen radical production by tumor necrosis factor alpha. Infection and Immunity 66 (1998) 1744-1747
228. Jones III C.I., Zhu H., Martin S.F., Han Z., Ki Y., and Alevridou B.R. Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells. Annals of Biomedical Engineering 35 (2007) 683-693
229. Jonkman J.H., Nicholson K.G., Farrow P.R., Eckert M., Grasmeijer G., Oosterhuis B., et al. Effects of alpha-interferon on theophylline pharmacokinetics and metabolism. British Journal of Clinical Pharmacology 27 (1989) 795-802
230. Julkunen I., Melen K., Nyqvist M., Pirhonen J., Sareneva T., and Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 19 Suppl. 1 (2000) S32-S37
231. Jyonouchi H., Sun S., and Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology 120 (2001) 170-179
232. Kalvakolanu D.V., Liu J., Hanson R.W., Harter M.L., and Sen G.C. Adenovirus E1A represses the cyclic AMP-induced transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in hepatoma cells. Journal of Biological Chemistry 267 (1992) 2530-2536
233. Kang K.-M., Choi I.-U., Shin D.-W., and Lee Y.-H. Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamethasone. Korean Journal of Parasitology 44 (2006) 209-219
234. Kapiotis S., Holzer G., Schaller G., Haumetr M., Widhalm H., Weghuber D., et al. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arteriosclerosis, Thrombosis, and Vascular Biology 26 (2006) 2541-2546
235. Karabiber H., Yakinci C., Durmaz Y., Temel I., and Mehmet N. Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine. Brain Development 26 (2004) 15-18
236. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273 (1996) 228-231
237. Karuzina I.I., and Archakov A.I. Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions. Free Radical Biology and Medicine 17 (1994) 557-567
238. Kasper L., Courret N., Darche S., Luangsay S., Mennechet F., Minns L., et al. Toxoplasma gondii and mucosal immunity. International Journal of Parasitology 34 (2004) 401-409
239. Kawaguchi R., Ozawa-Kondo M., Ohta-Misaki I., Suzuki-Karasaki M., Hayakawa S., Yamamoto T., et al. Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells. Nihon Rinsho Meneki Gakkai Kaishi 28 (2005) 407-412
240. Kawai Y., and Arinze I.J. Valproic acid-induced gene expression through production of reactive oxygen species. Cancer Research 66 (2006) 63-69
241. Kaye J.A., del Mar Melero-Montes M., and Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. British Medical Journal 322 (2001) 460-463
242. Kearns G.L. Pharmacogenetics and development: Are infants and children at increased risk for adverse outcomes?. Current Opinion in Pediatrics 7 (1995) 220-233
243. Kern J.K. Purkinje cell vulnerability and autism: A possible etiological connection. Brain Development 25 (2003) 377-382
244. Khan I.A., Schwartzman J.D., Matsuura T., and Kasper L.H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 13955-13960
245. Khatsenko O.G., Gross S.S., Rifkind A.B., and Vane J.R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulation. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 11147-11151
246. Kim J.C., Choi S.H., Kim J.K., Kim Y., Kim H.J., Im J.S., et al. Herpes simplex virus type 1 ICP27 induces apoptotic cell death by increasing intracellular reactive oxygen species. Molekuliarnaia Biologia (Moskow) 42 (2008) 470-477
247. Kim S.K., and Boothroyd J.C. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. Journal of Immunology 174 (2005) 8038-8048
248. Kimura H., Minakami H., Ohbuchi M., Yamaki N., Tsuchida S., Kanazawa K., et al. Release of superoxide anion from polymorphonuclear leukocytes stimulated by rubella viral antigen-antibody complex in vitro. Acta Virologica 41 (1997) 329-332
249. King M.D., Lindsay D.S., Holladay S., and Ehrich M. Neurotoxicity and immunotoxicity in CBA/J mice with chronic Toxoplasma gondii infection and single-dose exposure to methylmercury. International Journal of Toxicology 22 (2003) 53-61
250. Kirchheiner J., Bauer S., Meineke I., Rohde W., Prang V., Meisel C., et al. Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics 12 (2002) 101-109
251. Kirchheiner J., Brockmöller J., Meineke I., Bauer S., Rohde W., Meisel C., et al. Impact of CYP2C9 amino acid polymorphisms on glyburid kinetics and on the insulin and glucose response in healthy volunteers. Clinical Pharmacology and Therapeutics 71 (2002) 286-296
252. Kishimoto T. The biology of interleukin-6. Blood 74 (1989) 1-10
253. Knapp M., Romeo R., and Beecham J. Economic cost of autism in the UK. Autism 13 (2009) 317-336
254. Knickle L.C., Spencer D.F., and Renton K.W. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid. Biochemical Pharmacology 44 (1992) 604-608
255. Koizumi A., Walford R.L., and Imamura T. Treatment with poly I.C. enhances lipid peroxidation and the activity of xanthine oxidase, and decreases hepatic P-450 content and activities in mice and rats. Biochemistry and Biophysics Research Communications 134 (1986) 632-637
256. Konopka E., and Dzbeński T.H. Production of interferon-gamma and interleukin-10 by splenic cells of mice infected with Toxoplasma gondii or immunized with antigens of killed parasites. Wiadomości Parazytologiczne 47 Suppl. 1 (2001) 71-75
257. Koppe J.G., and Rothova A. Congenital toxoplasmosis. A long-term follow-up of 20 years. International Ophthalmology 13 (1989) 387-390
258. Koseoglu E., Yazar S., and Koc I. Is Toxoplasma gondii a causal agent in migraine?. American Journal of Medical Sciences (2009, June 26) [Epub ahead of print]
259. Kovacs I.J., Hegedus K., Pal A., and Pusztai R. Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. Placenta 28 (2007) 620-623
260. Kumon Y., Nakauchi Y., Suchiro T., Shiinoki T., Tanimoto N., Inoue M., et al. Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein downregulate paraoxonase 1 (PON1) expression by HepG2 cells. Amyloid 9 (2002) 160-164
261. Kunkel S.L., Lukacs N.W., Strieter R.M., and Chensue S.W. The role of chemokines in the immunopathology of pulmonary disease. Forum (Genova) 9 (1999) 339-355
262. Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O., et al. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200 (1994) 130-139
263. Lama G., Luongo I., Tirino G., Borriello A., Carangio C., and Salsano M.E. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. American Journal of Kidney Diseases 39 (2002) 958-965
264. Lang C., Groß U., and Lüder C.G.K. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitology Research 100 (2007) 191-203
265. Langouet S., Corcos L., Abdel-Razzak Z., Loyer P., Ketterer B., and Guillouzo A. Up-regulation of glutathion S-transferases alpha by interleukin 4 in human hepatocytes in primary culture. Biochemistry and Biophysics Research Communications 216 (1995) 793-800
266. Laso F.J., Vaquero J.M., Almeida J., Marcos M., and Orfao A. Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: Relationship with ethanol intake and liver disease. Cytometry B: Clinical Cytometry 72 (2007) 408-415
267. Lassoued S., Zabraniecki L., Marin F., and Billey T. Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 36 (2007) 262-263
268. Laval F., and Wink D.A. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 15 (1994) 443-447
269. Lee J.D., Rhoades K., and Economou J.S. Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6 and interferon-gamma. Immunology and Cell Biology 73 (1995) 57-61
270. Lee N., Wong C.K., Chan P.K., Lun S.W., Lui G., Wong B., et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clinical Infectious Diseases 45 (2007) 723-731
271. Lee S.C., Dickson D.W., Liu W., and Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon gamma. Journal of Neuroimmunology 46 (1993) 19-24
272. Lee Y., Rowe J., Eskue K., West J.R., and Maier S.E. Alcohol exposure on postnatal day 5 induces Purkinje cell loss and evidence of Purkinje cell degradation in lobule I of rat cerebellum. Alcohol 42 (2008) 295-302
273. Leeder J.S., and Kearns G.L. Pharmacogenetics in pediatrics. Implications for practice. Pediatric Clinics of North America 44 (1997) 55-77
274. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.-M., et al. Elevated immune response in the brain of autistic patients. Journal of Neuroimmunology 207 (2009) 111-116
275. Li Y., Ferrante A., Poulos A., and Harvey D.P. Neutrophil oxygen radical generation. Synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. Journal of Clinical Investigation 97 (1996) 1605-1609
276. Libbey J.E., Coon H.H., Kirkman N.J., Sweeten T.L., Miller J.N., Lainhart J.E., et al. Are there altered antibody responses to measles, mumps, or rubella viruses in autism?. Journal of Neurovirology 13 (2007) 252-259
277. Libbey J.E., Sweeten T.L., McMahon W.M., and Fujinami R.S. Autistic disorder and viral infections. Journal of Neurovirology 11 (2005) 1-10
278. Liew F.Y. The role of nitric oxide in parasitic diseases. Annals of Tropical Medicine and Parasitology 87 (1993) 637-642
279. Ligam P., Manuelpillai U., Wallace E.M., and Walker D. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: Implications for role of the kynurenine pathway in pregnancy. Placenta 26 (2005) 498-504
280. Lindova J., Novotna M., Havlicek J., Jozifkova E., Skallova A., Kolbekova P., et al. Gender differences in behavioural changes induced by latent toxoplasmosis. International Journal of Parasitology 36 (2006) 1485-1492
281. Lipkin W.I., and Hornig M. Microbiology and immunology of autism spectrum disorders. Novartis Foundation Symposium 251 (2003) 129-143
282. Lipton A., Hepner G.W., White D.S., and Harvey H.A. Decreased drug demethylation in patients receiving chemo-immunotherapy. Cancer 41 (1978) 1680-1684
283. Liverman C.S., Kaftan H.A., Cui L., Hersperger S.G., Taboada E., Klein R.M., et al. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neuroscience Letters 399 (2006) 220-225
284. Lokensgard J.R., Hu S., Sheng W., vanOijen M., Cox D., Cheeran M.C., et al. Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. Journal of Neurovirology 7 (2001) 208-219
285. Lonart G., Wang J., and Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. European Journal of Pharmacology 220 (1992) 271-272
286. London E., and Etzel R. The environment as an etiologic factor in autism: A new direction for research. Environmental Health Perspectives 108 Suppl. 3 (2000) 401-404
287. Lopez-Figueroa M.O., Day H.E.W., Lee S., Rivier C., Akil H., and Watson S.J. Temporal and anatomical distribution of nitric oxide synthase mRNA expression and nitric oxide production during central nervous system inflammation. Brain Research 852 (2000) 239-246
288. Löser H. Alcohol and pregnancy-embryopathy and alcohol effects. Therapeutische Umschau, Revue therapeutique 57 (2000) 246-252
289. Loyer P., Ilyin G., Abdel-Razzak Z., Banchereau J., Dezier J.F., Campion J.P., et al. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Letters 336 (1993) 215-220
290. Luft B.J., and Remington J.S. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 15 (1992) 211-222
291. Lukacs N.W., Hogaboam C., Campbell E., and Kunkel S.L. Chemokines: Function, regulation and alteration of inflammatory responses. Chemical Immunology 72 (1999) 102-120
292. Lukacs N.W. Migration of helper T-lymphocyte subsets into inflamed tissues. Journal of Allergy and Clinical Immunology 106 (2000) 264-269
293. Majewska M.D., Harrison N.L., Schwartz D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (Washington, DC) 232 (1986) 1004-1007
294. Makani S., Gollapudi S., Yel L., Chiplunkar S., and Gupta S. Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: A major role of mitochondrial pathway. Genes and Immunity 3 (2002) 270-278
295. Makay B., Makay O., Yenisey C., Icoz G., Ozgen G., Unsal E., et al. The interaction of oxidative stress response with cytokines in the thyrotoxic rat: Is there a link?. Mediators of Inflammation (2009, March 30) 10.1155/2009/391682
296. Malmgaard L., Paludan S.R., Mogensen S.C., and Ellermann-Eriksen S. Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-κB. Journal of General Virology 81 (2000) 3011-3020
297. Mannering G.J., Renton K.W., el Azhary R., and Deloria L.B. Effects of interferon-inducing agents on hepatic cytochrome P-450 drug metabolizing systems. Annals of New York Academy of Sciences 350 (1980) 314-331
298. Marangoni A., Accardo S., Aldini R., Guardigli M., Cavrini F., Sambri V., et al. Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kuppfer cells stimulated by Leptospira interrogans and Borrelia burgdorferi. World Journal of Gastroenterology 12 (2006) 3077-3081
299. Margolis T.P., Imai Y., Yang L., Vallas V., and Krause P.R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: Role of latency-associated transcripts. Journal of Virology 81 (2007) 1872-1878
300. Matalka K.Z. The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuro Endocrinology Letters 24 (2003) 185-191
301. Mathew M.J., and Chandy M.J. Central nervous system toxoplasmosis in acquired immunodeficiency syndrome. Neurology India 47 (1999) 182-187
302. Matsumoto K., Ohi H., and Kanmatsuse K. Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis. Nephron 78 (1998) 403-409
303. Matsunaga T., Nagata K., Tanaka E., Oguri K., and Yoshimura H. Effect of co-administration of interferon inducer, polyriboinosinic acid-polyribocytidylic acid, with SKF 525-A on hepatic drug metabolizing enzymes of rats. Journal of Pharmacobiodynamics 9 (1986) 638-644
304. Matthiesen L., Ekerfelt C., Berg G., and Ernerudh J. Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy. American Journal of Reproductive Immunology 39 (1998) 362-367
305. Matthys P., and Billiau A. Cytokines and cachexia. Nutrition 13 (1997) 763-770
306. Matyszak M.K. Inflammation in the CNS: Balance between immunological priviledge and immune response. Progress in Neurobiology 56 (1998) 19-35
307. Mayes P. Biologic oxidation. In: Harper H.A. (Ed). Review of physiological chemistry (1973), Lange Medical Publications, Los Altos, CA 165-184
308. McCarthy H.D., O'Saughnessy C.T., and Rothwell N.J. Endogenous mediators of cerebral ischemia induced hypermetabolism in the rat. British Journal of Pharmacology 98 Suppl. I (1989) 838P
309. McCarthy M., and Hendren R.L. Autism spectrum disorders have increased dramatically in prevalence in recent years. Preface. Psychiatric Clinic of North America 32 (2009) xiii1-xiii10
310. McCarthy S.M., and Davis C.D. Prooxidant diet provides protection during murine infection with Toxoplasma gondii. Journal of Parasitology 89 (2003) 886-894
311. McGary J.D. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
312. Mcintosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. Journal of Pediatrics 93 (1978) 33-36
313. McVicker B.L., Tuma D.J., Kharbanda K.K., Kubik J.L., and Casey C.A. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kuppfer cells in the presence of apoptotic cells. Alcoholism, Clinical and Experimental Research 31 (2007) 122-129
314. Melchert M., and List A. The thalidomide saga. International Journal of Biochemistry and Cell Biology 39 (2007) 1489-1499
315. Melke J., Goubran-Botros H., Chaste P., Betancur P., Nygren G., Anckarsäter H., et al. Abnormal melatonin synthesis in autism spectrum disorders. Molecular Psychiatry 13 (2008) 90-98
316. Meredith C.G., Christian C.D., Johnson R.F., Troxell R., Davis G.L., and Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clinical Pharmacology and Therapeutics 37 (1985) 396-401
317. Meyding-Lamade U., Seyfer S., Haas J., Dvorak F., Kehm R., Lamade W., et al. Experimental herpes simplex virus encephalitis: Inhibition of the expression of inducible nitric oxide synthase in mouse brain tissue. Neuroscience Letters 318 (2002) 21-24
318. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Immunological stress at the maternal-foetal interface: A link between neurodevelopment and adult psychopathology. Brain, Behavior and Immunity 20 (2006) 378-388
319. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., and Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signalling. Molecular Psychiatry 13 (2008) 208-221
320. Meyer U., Nyfeller M., Engler A., Urwyler A., Schedlowski M., Knuessel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. Journal of Neuroscience 26 (2006) 4752-4762
321. Mian M.F., Kang C., Lee S., Choi J.H., Bae S.S., Kim S.H., et al. Cleavage of focal adhesion kinase is an early marker and modulator of oxidative stress-induced apoptosis. Chemico-Biological Interactions 171 (2008) 57-66
322. Miksys S., Hoffmann E., and Tyndale R.F. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochemical Pharmacology 59 (2000) 1501-1511
323. Miller M.T., Stromland K., Ventura L., Johansson M., Bandim J.M., and Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: A mini review. International Journal of Developmental Neuroscience 23 (2005) 201-219
324. Miller M.T., and Strömland K. Thalidomide embryopathy: An insight into autism?. Teratology 47 (1993) 387-388
325. Miller R., Wen X., Dunford B., Wang X., and Suzuki Y. Cytokine production of CD8+ immune T cells but not of CD4+ T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages. Journal of Interferon Cytokine Research 26 (2006) 787-792
326. Mills J.L., Hediger M.L., Molloy C.A., Chrousos G.P., Manning-Courtnej P., Yu K.F., et al. Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clinical Endocrinology (Oxford) 67 (2007) 230-237
327. Min K.-J., Yang M., Kim S.-U., Jou I., and Joe E. Astrocytes induce hemoxygenase-1 expression in microglia: A feasible mechanism for preventing excessive brain inflammation. Journal of Neuroscience 26 (2006) 1880-1887
328. Minayamiyma Y., Takemura S., Imaoka S., Funae Y., Tanimoto Y., and Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. Journal of Pharmacology and Experimental Therapeutics 283 (1997) 1479-1485
329. Minns L.A., Buzoni-Gatel D., Ely K.H., Rachinel N., Luangsay S., and Kasper L.H. A novel triterpenoid induces transforming growth factor beta production by intraepithelial lymphocytes to prevent ileitis. Gastroenterology 127 (2004) 119-126
330. Miyazaki K., Narita N., and Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism. International Journal of Developmental Neurosciences 23 (2005) 287-297
331. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Cortney P., et al. Elevated cytokine levels in children with autism spectrum disorder. Journal of Neuroimmunology 172 (2006) 198-205
332. Moncion A., Truong N.T., Garrone A., Beaune P., Barouki R., and De Waziers I. Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin. Journal of Biological Chemistry 277 (2002) 45904-45910
333. Monshouwer M., Witkamp R.F., Nujmeijer S.M., Van Amsterdam J.G., and Van Miert A.S. Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary culture of pig hepatocytes. Toxicology and Applied Pharmacology 137 (1996) 237-244
334. Montero-Menei C.N., Sindij L., Garcion E., Mege M., Couez D., Gamelin E., et al. Early events of the inflammatory reaction induced in rat brain by lipopolysacharide intracerebral injection: Relative contribution of peripheral monocytes and activation microglia. Brain Research 724 (1996) 55-66
335. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., et al. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 37 (2000) 489-497
336. Morahan P.S., Munson A.E., Regelson W., Commerford S.L., and Hamilton L.D. Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size. Proceedings of the National Academy of Sciences of the United States of America 69 (1972) 842-846
337. Mordue D.G., Monroy F., La Regina M., Dinarello C.A., and Sibley L.D. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Journal of Immunology 167 (2001) 4574-4584
338. Morel Y., and Baroukis R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Journal of Biological Chemistry 273 (1998) 26969-26976
339. Morgan E.T., and Norman C.A. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metabolism and Disposition 18 (1990) 649-653
340. Morgan E.T. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rl.polyrC. Biochemical Pharmacology 42 (1991) 51-57
341. Mouridsen S.E., Rich B., and Isager T. Body mass index in male and female children with infantile autism. Autism 6 (2002) 197-205
342. Munoz J.J., Arai H., Bergman R.K., and Sadowski P.L. Biological activities of crystalline pertussigen from Bordetella pertussis. Infection and Immunity 33 (1981) 820-826
343. Muntane-Relat J., Ourlin J.C., Domergue J., and Maurel P. Differential effects of cytokines on the inducible expression of CYPA1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22 (1995) 1143-1153
344. Myslivec J., Hassmannova J., Barcal J., S'afanda J., and Z'alud V. Inhibitory learning and memory in newborn rats influenced by nitric oxide. Neuroscience 71 (1996) 299-312
345. Nagano Y., Mizunoe K., Maehara N., and Kumazawa Y. Induction of virus-inhibiting factor or interferon by cell fractions of Mycobacterium tuberculosis. Japanese Journal of Microbiology 15 (1971) 542-544
346. Nagineni C.N., Detrick B., and Hooks J.J. Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: A possible role in the immunopathogenesis of retinochoroiditis. Clinical and Experimental Immunology 128 (2002) 372-378
347. Nanson J.L. Autism in fetal alcohol syndrome: A report of six cases. Alcoholism, Clinical and Experimental Research 16 (1992) 558-565
348. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., and Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: Putative animal models for autism. Pediatric Research 52 (2002) 576-579
349. Nataf R., Skorupka C., Amet L., Lam A., Springbett A., and Lathe R. Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity. Toxicology and Applied Pharmacology 214 (2006) 99-108
350. Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. Journal of Experimental Medicine 158 (1983) 670-689
351. Neuhaus T.J., Wadhwa M., Callard R., and Barrat T.M. Increased IL2, IL4, and interferon-gamma (INF-) in steroid-sensitive nephrotic syndrome. Clinical and Experimental Immunology 100 (1995) 475-479
352. Ng D.S., Chu T., Esposito B., Hui P., Connelly P.W., and Gross P.L. Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovascular Pathology 17 (2008) 226-232
353. Nguyen T.D., Bigaignon G., Markine-Goriaynoff D., Heremans H., Nguyen T.N., Warnier G., et al. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL-12 and gamma-interferon. Journal of Medical Microbiology 52 (2003) 869-876
354. Nicholson T.E., and Renton K.W. The role of cytokines in the depression of CYP1A activity using cultured astrocytes as an in vitro model of inflammation in the central nervous system. Drug Metabolism and Disposition 30 (2002) 42-46
355. Nissapatorn V., Lee C., Quek K.F., Leong C.L., Mahmud R., and Abdullah K.A. Toxoplasmosis in HIV/AIDS patients: A current situation. Japanese Journal of Infectious Disease 57 (2004) 160-165
356. Norris P.J., Hardwick J.P., and Emson P.C. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. Journal of Comparative Neurology 366 (1996) 244-258
357. Novotna M., Hanusova J., Klose J., Preiss M., Havlicek J., Roubalova K., et al. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infectious Diseases 5 (2005) 54
358. Nunes C., Almeida L., and Laranjinha J. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease. Neurochemistry International 47 (2005) 173-182
359. Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endoxin. Journal of Experimental Medicine 176 (1992) 261-264
360. Ohga S., Miyazaki C., Okada K., Akazawa K., and Ueda K. The inflammatory cytokines in measles: Correlation between serum interferon-gamma levels and lymphocyte subpopulations. European Journal of Pediatrics 151 (1992) 492-496
361. Okada H., Araga S., Takeshima T., and Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache 38 (1998) 39-42
362. Okada K., Tanaka K., Noda S., Okazaki M., and Koga Y. Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice lately infected with the virus. Archives of Virology 144 (1999) 2273-2290
363. Okuno H., Takasu M., Kano H., Seki T., Shiozaki Y., and Inoue K. Depression of drug-metabolizing activity in the human liver by interferon-beta. Hepatology 17 (1993) 65-69
364. Oliveira J.G., Silva N.M., Santos A.A., Souza M.A., Ferreira G.L., Mineo J.R., et al. BeWo trophoblasts are unable to control replication of Toxoplasma gondii, even in the presence of exogenous IFN-gamma. Placenta 27 (2006) 691-698
365. Oliviera G., Diogo L., Grazina M., Garcia P., Borges L., Vicente A., et al. Mitochondrial dysfunction in autism spectrum disorders. Developmental Medicine and Child Neurology 47 (2005) 185-189
366. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Vierkant R.A., Pankratz V.S., Jacobsen S.J., et al. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics 56 (2005) 798-807
367. Ovsyannikova I.G., Reid K.C., Jacobson R.M., Oberg A.L., Klee G.G., and Poland G.A. Cytokine production patterns and antibody response to measles vaccine. Vaccine 21 (2003) 3946-3953
368. Ozaki Y., Edelstein M.P., and Duch D.S. The actions of interferon and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes. Biochemistry and Biophysics Research Communications 144 (1987) 1147-1153
369. Paintlia M.K., Paintlia A.S., Barbosa E., Singh I., and Singh A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. Journal of Neuroscience Research 78 (2004) 347-361
370. Palmer B.S. Meta-analysis of three cases controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 16 (2007) 657-663
371. Paludan S.R. Synergistic action of pro-inflammatory agents: Cellular and molecular aspects. Journal of Leukocyte Biology 67 (2000) 18-25
372. Pampori N.A., and Shapiro B.H. Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology 140 (1999) 1245-1254
373. Parola M., Bellomo G., Robino G., Barrera G., and Dianzani M.U. 4-Hydroxynonenal as a biological signal: Molecular basis and pathophysiological implications. Antioxidant Redox Signalling 1 (1999) 255-284
374. Pasca S.P., Nemes B., Vlase L., Gagyi C.E., Dronca E., Miu A.C., et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sciences 78 (2006) 2244-2248
375. Patja A., Davidkin I., Kurki T., Kallio M.J., Valle M., and Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatric Infectious Diseases Journal 19 (2000) 1127-1134
376. Paton T.E., and Renton K.W. Cytokine-mediated down-regulation of CYP1A1 in hepal cells. Biochemical Pharmacology 55 (1998) 1791-1796
377. Paucha Smith, S. E. (2008). Maternal immune activation and abnormal behavior in the adult offspring: Towards a mechanism. PhD Thesis, California Institute of Technology, California, Pasedena.
378. Pavlov V.A. Cholinergic modulation of inflammation. International Journal of Clinical and Experimental Medicine 1 (2008) 203-212
379. Pelloux H., Pernod G., Polack B., Coursange E., Richard J., Vrna J.M., et al. Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells. Parasitology Research 82 (1996) 598-603
380. Peng B.W., Lin J., Lin J.Y., Jiang M.S., and Zhang T. Exogenous nitric oxide induces apoptosis in Toxoplasma gondii tachyzoites via a calcium signal transduction pathway. Parasitology 126 (2003) 541-550
381. Penn L.J., and Williams B.R. Interferon-induced 2-5A synthetase activity in human peripehral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines. Journal of Virology 49 (1984) 748-753
382. Pereda J., Sabater L., Aparisi L., Escobar J., Sandoval J., Vina J., et al. Interaction between cytokines and oxidative stress in acute pancreatitis. Current Medical Chemistry 13 (2006) 2775-2787
383. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., et al. Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. American Journal of Psychiatry 158 (2001) 1058-1066
384. Persico A.M., Militerni R., Bravaccio C., Schneider C., Melmed R., Trillo S., et al. Adenosine deaminase alleles and autistic disorder: Case-control and family-based association studies. American Journal of Medical Genetics 96 (2000) 784-790
385. Peterson P.K., Gekker G., Hu S., and Chao C.C. Human astrocytes inhibit intracellular multiplication of Toxoplasma by a nitric oxide-mediated mechanism. Journal of Infectious Diseases 171 (1995) 516-518
386. Peterson P.K., Gekker G., Hu S., and Chao C.C. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. Journal of Infectious Diseases 168 (1993) 1472-1478
387. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry 276 (2001) 36734-36741
388. Piao L.X., Aosai F., Mun H.S., and Yano A. Peroral infectivity of Toxoplasma gondii in bile and feces of interferon-gamma knockout mice. Microbiology and Immunology 49 (2005) 239-243
389. Pichichero M.E., Cernichiari E., Lopreiato J., and Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerasol: A descriptive study. Lancet 360 (2002) 1737-1741
390. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 16 (2000) 1009-1012
391. Pollmächer T., Schuld A., Kraus T., Haack M., and Hinze-Selch D. On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors. Fortschritte der Neurologie-Psychiatrie 69 (2001) 65-74
392. Pomel S., Luk F.C., and Beckers C.J. Host cell egress and invasion induce marked relocations of glycolytic enzymes in Toxoplasma gondii tachyzoites. PLoS Pathogens 4 (2008) e1000188
393. Prada J., and Ngo-Tu T. Overexpression and protective role of interleukin-6, tumor necrosis factor-alpha and nitric oxide in experimental and clinical ocular toxoplasmosis. Abstracts of the 13th international congress on infectious diseases. International Journal of Infectious Diseases 12 (2008) 10.1016/j.ijid.2008.05.1025 e388 (65.037)
394. Prandota J. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice. Research in Autism Spectrum Disoders 4 (2010) 103-118
395. Prandota J. The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. International Journal of Neuroscience 119 (2009) 2144-2182
396. Prandota, J. (2010a). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis. Effect of various diseases and clinical states. International Journal of Neuroscience.
397. Prandota, J. (2010b). Idiopathic intracranial hypertension may be caused by reactivation of latent cerebral toxoplasmosis probably because of disturbances in the host and/or Toxoplasma gondii immune defense mechanisms. Effect of various medications and biologic agents. Recent Patents on CNS Drug Discovery.
398. Prandota J. Possible pathomechanisms of sudden infant death syndrome. Key role of chronic hypoxia, cytokine irregularities, and metabolic trauma in genetically predisposed infants. American Journal of Therapeutics 11 (2004) 517-546
399. Prandota J. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in non-human immunodeficiency virus-infected subjects with no lymphadenopathy. The parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. American Journal of Therapeutics 14 (2007) 63-105
400. Prandota J. Urinary tract diseases revealed after DTP vaccination in infants and young children. Cytokine irregularities and down-regulation of cytochrome P-450 enzymes induced by the vaccine may uncover latent diseases in genetically predisposed subjects. American Journal of Therapeutics 11 (2004) 344-353
401. Prandota J. Viral infections and resulting inhibition of xenobiotic metabolizing enzymes as the cause of autoimmune hepatitis in a genetically predisposed person persistently exposed to harmful environmental factor(s). Autoimmunity 34 (2001) 155-156
402. Prandota J. Unusual distribution, pharmacokinetics, and metabolism of some drugs and their implications to pharmacotherapy. American Journal of Therapeutics 7 (2000) 332-340
403. Prandota J. Possible pathomechanism of autoimmune hepatitis. American Journal of Therapeutics 10 (2003) 51-57
404. Prandota J. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatoxicity. Depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. American Journal of Therapeutics 12 (2005) 254-261
405. Prawan A., Buranrat B., Kukongviriyapan U., Sripa B., and Kukongviriyapan V. Inflammatory cytokines suppress NAD(P)H:quinone oxidoreductase-1 and induce oxidative stress in cholangiocarcinoma cells. Journal of Cancer Research and Clinical Oncology 135 (2009) 515-522
406. Pukhalsky A.L., Shmarina G.V., Bliacher M.S., Fedorova I.M., Toptygina A.P., Fisenko J.J., et al. Cytokine profile after rubella vaccine inoculation: Evidence of the immunosuppressive effect of vaccination. Mediators of Inflammation 12 (2003) 203-207
407. Pulliam L., Moore D., and West D.C. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: Possible role in neurotoxicity. Journal of Neurovirology 1 (1995) 219-227
408. Puntarulo S., and Cederbaum A.I. Inhibition of ferritin-stimulated microsomal production of reactive oxygen intermediates by nitric oxide. Archives of Biochemistry and Biophysics 340 (1997) 19-26
409. Puntarulo S., and Cederbaum A.I. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radicals in Biology and Medicine 24 (1998) 1324-1330
410. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., and Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57 (2001) 1618-1628
411. Pusch L., Romeike B., Deckert M., and Mawrin C. Persistent toxoplasma bradyzoite cysts in the brain: Incidental finding in an immunocompetent patient without evidence of a toxoplasmosis. Clinical Neuropathology 28 (2009) 210-212
412. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerosis plaque stability. Journal of Clinical investigation 98 (1996) 2572-2579
413. Rakasz E., Gal A., Biro J., Balas G., and Falus A. Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)1 beta, IL-6 and tumor necrosis factor (TNF)-alpha. Scandinavian Journal of Immunology 37 (1993) 684-689
414. Ramanathan M., Giladi A., and Leibovich S.J. Regulation of vascular endothelial growth factor gene expression in murine macrophages by nitric oxide and hypoxia. Experimental Biology and Medicine (Maywood) 228 (2003) 697-705
415. Rane A., Liu Z., Levol R., Bjelfman C., Thyr C., Ericson H., et al. Differential effects of neuroleptic agents on hepatic cytochrome P-450 isoenzymes in the male rat. Biochimica et Biophysica Acta 1291 (1996) 60-66
416. Rasmussen E., Ask B., Finnström N., Skottner-Lundin A., and Rane A. Insulin-like growth factor 1 (IGF-1) effects on sex-specific cytochrome P450 enzymes in normal and hypophysectomised male rats. Biochemical Pharmacology 56 (1998) 459-466
417. Raymond J., Poissonniere M.H., Thulliez P.H., Forestrier F., Daffos F., and Lebon P. Presence of gamma interferon in human acute and congenital toxoplasmosis. Journal of Clinical Microbiology 28 (1990) 1434-1437
418. Reichenberg A., Kraus T., Haack M., Schuld A., Pollmächer T., and Yirmiya R. Endotoxin-induced changes in food consumption in healthy volunteers: Association with TNF-alpha and IL-6. Psychoneuroendocrinology 27 (2002) 945-956
419. Reiter-Owona I., Seitz H., Gross U., Sahm M., Rockstroh J.K., and Seitz H.M. Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients?. Journal of Parasitology 86 (2000) 531-536
420. Remington J.S., McLeod R., Thulliez P., and Desmonts G. Toxoplasmosis. In: Remington J.S., and Klein J.O. (Eds). Infectious diseases of the fetus and newborn infant (2001), WB Saunders, Philadelphia 205-346
421. Renton K.W., Deloria L.B., and Mannering G.J. Effects of polyriboinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes. Molecular Pharmacology 14 (1978) 672-681
422. Renton K.W., Gray J.D., and Hall R. Decreased elimination of theophylline after influenza vaccination. Canadian Medical Association Journal 123 (1980) 288-290
423. Renton K.W., Keyler D.E., and Mannering G.J. Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers, poly rl-rC and tilorone. Biochemistry and Biophysics Research Communications 88 (1979) 1017-1023
424. Renton K.W., and Mannering G.J. Depression of hepatic cytochrome P-450 dependent monooxydase systems with administered interferon inducing agents. Biochemistry and Biophysics Research Communications 73 (1976) 343-348
425. Renton K.W., and Nicholson T.E. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. Journal of Pharmacology and Experimental Therapeutics 294 (2000) 524-530
426. Renton K.W. Hepatic drug metabolism and immunostimulation. Toxicology 142 (2000) 173-178
427. Renton K.W. The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoin. Journal of Pharmacology and Experimental Therapeutics 208 (1979) 267-270
428. Riley E.P., and McGee C.L. Fetal alcohol spectrum disorders: An overview with emphasis on changes in brain and behavior. Experimental Biology and Medicine (Maywood) 230 (2005) 357-365
429. Rimland B. The autism epidemic, vaccinations, and mercury. Journal of Nutrition and Environmental Medicine 10 (2000) 261-266
430. Rivest S., Lacroix S., Vallieres L., Nadeau S., Zhang J., and Laflamme N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proceedings of the Society for Experimental Biology and Medicine 223 (2000) 22-38
431. Robbins M.S., and Mannering G.J. Effects of the interferon inducing agents tilorone and polyriboinosinic acid. polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of pregnant and fetal rats. Biochemical Pharmacology 33 (1984) 1213-1222
432. Roberts C.W., Cruickshank S.M., and Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal difference in cytokine production. Infection and Immunity 63 (1995) 2549-2555
433. Rollins B.J. Monocyte chemoattractant protein-1: A potent regulator of monocyte recruitment in inflammatory disease. Molecular Medicine Today 2 (1996) 198-204
434. Rorman E., Zamir C.S., Rilkis I., and Ben-David H. Congenital toxoplasmosis-Prenatal aspects of Toxoplasma gondii infection. Reproduction Toxicology 21 (2006) 458-472
435. Rosales-Corral S., Tan D.X., Reiter R.J., Valdivia-Velazquez M., Martinez-Barnosa G., Acosta-Martinez J.P., et al. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta in rat brain: A comparative, in vivo study versus vitamic C and E. Journal of Pineal Research 35 (2003) 80-84
436. Rossignol D.A. Hyperbaric oxygen therapy might improve certain pathopgysiological findings in autism. Medical Hypotheses 68 (2007) 1208-1227
437. Roubenoff R., Freeman L.M., Smith D.E., Abad L.W., Dinarello C.A., and Kehayias J.J. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis and Rheumatism 40 (1997) 534-539
438. Roubenoff R., Grinspoon S., Skolnik P.R., Tchcetgen E., Abad L., Spiegelman D., et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. American Journal of Physiology, Endocrinology and Metabolism 283 (2002) E138-E145
439. Roubenoff R., Roubenoff R.A., Cannon J.G., Kehayias J.J., Zhuang H., Dawson-Hughes B., et al. Rheumatoid cachexia: Cytokine-driven hypermetabolism and loss of lean body mass in chronic inflammation. Journal of Clinical Investigation 93 (1994) 2379-2386
440. Ryan M., Gothefors L., Storsaeter J., and Mills K.H. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with acellular vaccine: Comparison of the T cell cytokine profiles in infants and mice. Developments in Biological Standardization 89 (1997) 297-305
441. Ryan M., Murphy G., Ryan E., Nilsson L., Shackley F., Gothefors L., et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93 (1998) 1-10
442. Saemundsen E., Ludvigsson P., Hilmarsdottir I., and Rafnsson V. Autism spectrum disorders in children with seizures in the first year of life-a population based study. Epilepsia 48 (2007) 1724-1730
443. Saffer L.D., Long Krug S.A., and Schwartzman J.D. The role of phospholipase in host cell penetration by Toxoplasma gondii. American Journal of Tropical Medicine and Hygiene 40 (1989) 145-149
444. Sakai H., Okamoto T., and Kikkawa Y. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid: Polyribocytidylic acid. Journal of Pharmacology and Experimental Therapeutics 263 (1992) 381-386
445. Sanganahalli B.G., Joshi P.G., and Joshi N.B. Xanthine oxidase, nitric oxide synthase and phospholipase A(2) produce reactive oxygen species via mitochondria. Brain Research 1037 (2005) 200-203
446. Santello F.H., Frare E.O., dos Santos C.D., Toldo M.P., Kawasse L.M., Zucoloto S., et al. Melatonin treatment reduces the severity of experimental Trypanosoma cruzi infection. Journal of Pineal Research 42 (2007) 359-363
447. Santello F.H., Frare E.O., Caetano L.C., Alonso Toldo M.P., and do Prado Jr. J.C. Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease. Journal of Pineal Research 45 (2008) 79-85
448. Sarciron M.E., Walchshofer N., Paris J., Petavy A.F., and Peyron F. Phenylalanine derivatives active against Toxoplasma gondii brain cysts in mice. Parasite 5 (1998) 359-364
449. Sasaki K., Cripe T.P., Koch S.R., Andreone T.L., Petersen D.D., Beale E.G., et al. Multihormonal regulation of phosphoetanolpyruvate carboxykinase gene transcription. The dominant role of insulin. Journal of Biological Chemistry 259 (1984) 15242-15251
450. Sass-Kortsak A. Copper metabolism. Advances in Clinical Chemistry 8 (1965) 1-67
451. Schneider T., and Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
452. Schneider-Schaulies J., Schneider-Schaulies S., and Ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infection in human glial cells. Virology 195 (1993) 219-228
453. Schröcksnadel K., Widner B., Bergant A., Neurauter G., Schröcksnadel H., and Fuchs D. Tryptophan degradation during and after gestation. Advances in Experimental Medicine and Biology 527 (2003) 77-83
454. Schuetz J., Beach D., and Guzelian P. Selective expression of cytochrome P450 CYP3A in embryonic and adult human liver. Pharmacogenetics 4 (1994) 11-20
455. Seabra S.H., de Souza W., and Damatta R.A. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion. Biochemistry and Biophysics Research Communications 324 (2004) 744-752
456. Seeber F. An enzyme-release assay for the assessment of the lytic activities of complement or antimicrobial peptides on extracellular Toxoplasma gondii. Journal of Microbiological Methods 39 (2000) 189-196
457. Seiler K.P., Vavrin Z., Eichwald E., Hibbs Jr. J.B., and Weis J.J. Nitric oxide production during murine Lyme disease: Lack of involvement in host resistance or pathology. Infection and Immunity 63 (1995) 3886-3895
458. Seng S., Makala L.H., Yokoyama M., Lim C., Choi Y.H., Suzuki N., et al. SAG1 is a host-targeted antigen for protection against Toxoplasma gondii infection. Pathobiology 71 (2004) 144-151
459. Shandrenko S.G., and Dmitrenko N.P. Nitric oxide synthesis in rats after BCG vaccination. Ukrainskii Biokhimicheskii Zhurnal 73 (2001) 55-60
460. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. Journal of Neuroscience 23 (2003) 297-302
461. Shi L., Tu N., and Patterson P.H. Maternal influenza infection is likely to alter fetal brain development indirectly: The virus is not detected in the fetus. International Journal of Developmental Neuroscience 23 (2005) 299-305
462. Shimada T., Yamazaki H., Mimura M., Inui Y., and Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 270 (1994) 414-423
463. Shimazawa R., Sano H., Tantani A., Miyachi H., and Hashimoto Y. Thalidomide as a nitric oxide synthase inhibitor and its structural development. Chemical and Pharmaceutical Bulletin (Tokyo) 52 (2004) 498-499
464. Shoenfeld Y., and Aron-Maor A. Vaccination and autoimmunity-"vaccinosis": A dangerous liaison?. Journal of Autoimmunity 14 (2000) 1-10
465. Shrestha S.P., Tomita T., Weiss L.M., and Orlofsky A. Proliferation of Toxoplasma gondii in inflammatory macrophages in vivo is associated with diminished oxygen radical production in the host cell. International Journal of Parasitology 36 (2006) 433-441
466. Sidorkina O., Espey M.G., Miranda K.M., Wink D.A., and Laval J. Inhibition of poly(ADP-ribose) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radicals in Biology and Medicine 35 (2003) 1431-1438
467. Sigfrid L.A., Cunningham J.M., Beeharry N., Lortz S., Tiedge M., Lenzen S., et al. Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells. Journal of Molecular Endocrinology 31 (2003) 509-518
468. Silva N.M., Tafuri W.L., Alvarez-Leite J.I., Mineo J.R., and Gazzinelli R.T. Toxoplasma gondii: In vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions. Microbes and Infection 4 (2002) 261-270
469. Singh V.K., and Jensen R.L. Elevated levels of measles antibodies in children with autism. Pediatric Neurology 28 (2003) 292-294
470. Singh V.K. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. Journal of Neuroimmunology 66 (1996) 143-145
471. Sladkova T., and Kostolansky F. The role of cytokines in the immune response to influenza A virus infection. Acta Virologica 50 (2006) 151-162
472. Snell J.C., Chernyshev O., Gilbert D.L., and Colton C.A. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. Journal of Leukocyte Biology 62 (1997) 369-373
473. Sögüt S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozuguriu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta 331 (2003) 111-117
474. Sorg O., Horn T.F., Yu N., Gruol D.L., and Bloom F.E. Inhibition of astrocyte glutamate uptake by reactive oxygen spcies: Role of antioxidant enzymes. Molecular Medicine 3 (1997) 431-440
475. Spear W., Chan D., Coppens I., Johnson R.S., Giaccia A., and Blader U. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiology 8 (2006) 339-352
476. Speer E.M., Gentile D.A., Zeevi A., Pillage G., Huo D., and Skoner D.P. Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Human Immunology 67 (2006) 915-923
477. Speir E., Shibutani T., Yu Z.X., Ferrans V., and Epstein S.E. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circulation Research 79 (1996) 1143-1152
478. Speir E. Cytomegalovirus gene regulation by reactive oxygen species, Agents in atherosclerosis. Agents in atherosclerosis. Annals of New York Academy of Sciences 899 (2000) 363-374
479. Stajich G.V., Lopez G.P., Harry S.W., and Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. Journal of Pediatrics 136 (2000) 679-681
480. Strobel H.W., Kawashima H., Geng J., Sequeira D., Bergh A., Hodgson A.V., et al. Expression of multiple forms of brain cytochrome P450. Toxicology Letters 82-83 (1995) 639-643
481. Strobl J.S., Cassel M., Mitchell S.M., Reilly C.M., and Lindsay D.S. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. Journal of Parasitology 93 (2007) 694-700
482. Strömland K., Nordin V., Miller M., Akerstrom B., and Gillberg C. Autism in thalidomide embryopathy: A population study. Developmental Medicine and Child Neurology 36 (1994) 351-356
483. Stubbs E.G., Ash E., and Williams C.P. Autism and congenital cytomegalovirus. Journal of Autism and Developmental Disorders 14 (1984) 183-189
484. Stubbs G. Interferonemia and autism. Journal of Autism and Developmental Disorders 25 (1995) 71-73
485. Stubbs G., Litt M., Lis E., Jackson R., Voth W., Lindberg A., et al. Adenosine deaminase activity decreased in autism. Journal of American Academy of Child Psychiatry 21 (1982) 71-74
486. Sugiyama T. A research of obesity in autism. Japanese Journal on Developmental Disabilities 13 (1991) 53-58
487. Summers A.M., Summers C.W., Drucker D.B., Hajeer A.H., Barson A., and Hutchinson I.V. Association of IL-10 genotype with sudden infant death syndrome. Human Immunology 61 (2000) 1270-1273
488. Sun H., and Mayhan W.G. Sex difference in nitric oxide synthase-dependent dilatation of cerebral arterioles during long-term alcohol consumption. Alcoholism, Clinical and Experimental Research 29 (2005) 430-436
489. Suzuki Y., Conley F.K., and Remington J.S. Importance of endogenous interferon-gamma in prevention of toxoplasmic encephalitis in mice. Journal of Immunology 145 (1989) 2045-2050
490. Suzuki Y., Orellana M.A., Schreiber R.D., and Remington J.S. Interferon-gamma: The major mediator of resistance against Toxoplasma gondii. Science 240 (1988) 516-518
491. Suzuki Y. Immunopathogenesis of cerebral toxoplasmosis. Journal of Infectious Diseases 186 Suppl. 2 (2002) S234-S240
492. Sweeten T.L., Posey D.J., and McDougle C.J. Brief report: Autistic disorder in three children with cytomegalovirus infection. Journal of Autism and Developmental Disorders 34 (2004) 583-586
493. Sweeten T.L., Posey D.J., Shankar S., and McDougle C.J. High nitric oxide production in autistic disorder: A possible role for interferon-gamma. Biology of Psychiatry 55 (2004) 434-437
494. Takeuchi E. Incidence of obesity among school children with mental retardation in Japan. American Journal of Mental Retardation 99 (1994) 283-288
495. Tanaka K., and Noda S. Role of nitric oxide in murine cytomegalovirus (MCMV) infection. Histology and Histopathology 16 (2001) 937-944
496. Tang R.A., Dorotheo E.U., Schiffman J.S., and Bahrani H.M. Medical and surgical management of idiopathic intracranial hypertension in pregnancy. Current Neurology and Neuroscience Reports 4 (2004) 398-409
497. Tapner M., Liddle C., Goodwin B., George J., and Farrel G.C. Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 24 (1996) 367-373
498. Tappel A.L. Lipid peroxidation damage to cell components. Federation Proceedings 32 (1973) 1870-1874
499. Tatro J.B., Romero L.I., Beasley D., Steere A.C., and Reichlin S. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. Journal of Infectious Diseases 169 (1994) 1014-1022
500. Taylor B., Miller E., Lingam R., Andrews N., Simmons A., and Stowe J. Measles, mumps, and rubella vaccinations and bowel problems or developmental regression in children with autism: Population study. British Medical Journal 16 (2002) 393-396
501. Taylor G.A., Jeffers M., Largasespada D.A., Jenkins N.A., Copeland N.G., and Vande Woude G.F. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon γ. Journal of Biological Chemistry 271 (1996) 20399-20405
502. Taylor G.A., Stauber R., Rulong S., Hudson E., Pei V., Pavlakis G.N., et al. The inducibly expressed GTPase localizes to the endoplasmatic reticulum, independently of GTP binding. Journal of Biological Chemistry 272 (1997) 10639-10645
503. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: From animals to humans. International Journal of Parasitology 30 (2000) 1217-1258
504. Tetteh J.K., Addae M.M., Ishiwada N., Yempewu S.M., Yamaguchi S., Ofori-Adjei D., et al. Plasma levels of Th1 and Th2 cytokines in Ghanaian children with vaccine-modified measles. European Cytokine Network 14 (2003) 109-113
505. Thal C., el Kahwaji J., Loeper J., Tinel M., Doostzadeh J., Labbe G., et al. Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat. Journal of Pharmacology and Experimental Therapy 268 (1994) 515-521
506. Thomas P.S., Ng C., Elsing M., and Yates D.H. Influenza vaccination: Changes in exhaled nitric oxide levels and sputum cytology. Respirology 4 (1999) 355-358
507. Thouvenin M., Candolfi E., Villard O., Klein J.P., and Kien T. Immune response in a murine model of congenital toxoplasmosis: Increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2 dependent. Parassitologia 39 (1997) 279-283
508. Tinel M., Elkahwaji J., Robin M.A., Fardel N., Descatoire V., Haouzi D., et al. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. Journal of Pharmacology and Experimental Therapy 289 (1999) 649-655
509. Toth F.D., Juhl C., Norskov-Lauritsen N., Mosborg Petersen P., and Ebbesen P. Interferon production by cultured human trophoblast induced with double stranded polyribonucleotide. Journal of Reproductive Immunology 17 (1990) 217-227
510. Trottier G., Srivastava L., and Walker C.D. Etiology of infantile autism: A review of recent advances in genetic and neurobiological research. Journal of Psychiatry and Neuroscience 24 (1999) 103-115
511. Truman J.W., De vente J., and Ball E.E. Nitric-oxide sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. Development 122 (1996) 3949-3958
512. Uchida K., Shiraishi M., Naito Y., Torii N., Nakamura Y., and Osawa T. Activation of stress signalling pathways by the end product of lipid peroxidation. Journal of Biological Chemistry 274 (1999) 2234-2242
513. Uchide N., Ohyama K., Bessho T., Yuan B., and Yamakawa T. Effect of antioxidants on apoptosis induced by influenza virus infection: Inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Research 56 (2002) 207-217
514. Ueda K., Nishida Y., Oshima K., and Shepard T.H. Congenital rubella syndrome: Correlations of gestational age at time of maternal rubella with type of defect. Journal of Pediatrics 94 (1979) 763-765
515. Unger R. Lipid overload and overflow: Metabolic trauma and the metabolic syndrome. Trends in Endocrinology and Metabolism 14 (2003) 398-403
516. UptoDate. Toxoplasmosis in HIV-infected patients (2007). http://patients.uptodate.com/topic.asp?file=hiv_infe/14374 Available at http://patients.uptodate.com/topic.asp?file=hiv_infe/14374 Accessed 16.10.07
517. Urakubo A., Jarskog L.F., Lieberman J.A., and Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophrenia Research 47 (2001) 27-36
518. U.S. Environmental Protection Agency. 1997 Mercury Study Report to Congress: Overview. www.epa.gov/mercury/reportover.htm. Last updated on Wednesday October 7th, 2009.
519. Van Reeth K. Cytokines in the pathogenesis of influenza. Veterinary Microbiology 74 (2000) 109-116
520. Vankelecom H., Carmeliet P., Heremans H., Van Damme J., Dijkmans R., Billiau A., et al. Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology 126 (1990) 1919-1926
521. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 57 (2005) 67-81
522. Veenstra van Nieuwenhoven A.L., Bouman A., Moes H., Heineman M.J., de Leij L.F., Santema J., et al. Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of ovarian cycle. Fertilisation and Sterility 77 (2002) 1032-1037
523. Veith G.L., and Rice G.E. Interferon gamma expression during human pregnancy and in association with labor. Gynecologic and Obstetric Investigation 48 (1999) 163-167
524. Verrotti A., Basciani F., Trotta D., Greco R., Morgese G., and Chiarelli F. Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1. Clinical and Experimental Medicine 1 (2001) 133-136
525. Von Mandach U., Lauth D., and Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy. Journal of Maternal and Fetal Neonatal Medicine 13 (2003) 22-27
526. Wakefield A.J., and Montgomery S.M. Autism, viral infection and measles-mumps-rubella-vaccination. The Israel Medical Association Journal 1 (1999) 183-187
527. Wakefield A.J., Murch S.H., Anthony A., Linnel J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet 351 (1998) 637-641
528. Walther B., Ghersi-Egea J.-F., Minn A., and Siest G. Brain mitochondrial cytochrome P-450scc: Spectral and catalytic properties. Archives of Biochemistry and Biophysics 254 (1987) 592-596
529. Waly M., Olteanu H., Banerjee R., Choi S.-W., Mason J.B., Parker B.S., et al. Activation of methionine synthase by insulin-like growth factor-1 and dopmaine: A target for neurodevelopmental toxins and thimerosal. Molecular Psychiatry 9 (2004) 358-370
530. Wang H., Wen L., and Ling X. Relationship of nitric oxide with intrauterine human cytomegalovirus active infection during early pregnancy. Zhonghua Fu Chan Ke Za Zhi 37 (2002) 663-665
531. Wang K., Deutschman C.S., Clemens M.G., and De Maio A. Reciprocal expression of phosphoenolpyruvate carboxykinase and acute phase genes during acute inflammation. Shock 3 (1995) 204-209
532. Wang X., and Suzuki Y. Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. Journal of Interferon and Cytokine Research 27 (2007) 599-605
533. Ward B.J., and Griffin D.E. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response. Clinical Immunology and Immunopathology 67 (1993) 171-177
534. Warner B., Wyss A., Yoshida S., and Gustafsson J.A. Cytochrome P450 enzymes in brain. Methods in Neuroscience 22 (1994) 51-66
535. Watanabe C., Kawashima H., Takekuma K., Hoshika A., and Watanabe Y. Increased nitric oxide production and GFAP expression in the brains of influenza A/NWS virus infected mice. Neurochemical Research 33 (2008) 1017-1023
536. Watts R.N., and Richardson D.R. The mechanism of nitrogen monoxide (NO)-mediated iron mobilization from cells. NO intercepts iron before incorporation into ferritin and indirectly mobilizes iron from ferritin in a glutathione-dependent manner. European Journal of Biochemistry 269 (2002) 3383-3392
537. Webster J.P., Lamberton P.H., Donnelly C.A., and Torrey E.F. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and antiparasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceedings: Biological Sciences 273 (2006) 1023-1030
538. Webster J.P., and Macdonald D.W. Survey of the parasites and pathogen carried by wild brown rats, Rattus norvegicus, on UK farmsteads. Parasitology 111 (1995) 247-255
539. Webster J.P. Prevalence and transmission of Toxoplasma gondii in wild brown rats, Rattus norvegicus, on UK farmsteads. Parasitology 108 (1994) 407-411
540. Wei G., Zhang M., Mei Y., and Dong J. Expression of cytokines IL-2, IL-10 and TNF-alpha in mice with herpes simplex viral encephalitis. Journal of Huazhong University of Science and Technology, Medical Sciences 26 (2006) 308-310
541. Weis M., Kledal T.N., Lin K.Y., Panchal S.N., Gao S.Z., Valantine H.A., et al. Cytomegalovirus infection impairs the nitric oxide synthase pathway: Role of assymetric dimethylarginine in transplant arteriosclerosis. Circulation 109 (2004) 500-505
542. Weissman B.A., Niu E., Ge R., Sottas C.M., Holmes M., Hutson J.C., et al. Paracrine modulation of androgen synthesis in rat leydig cells by nitric oxide. Journal of Andrology 26 (2005) 369-378
543. Whitman S.C., Argmann C.A., Sawyez C.G., Miller D.B., Hegele R.A., and Huff M.W. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon gamma. Journal of Lipid Research 40 (1999) 1017-1028
544. Wiest M.M., German J.B., Harvey D.J., Watkins S.M., and Hertz-Picciotto. Plasma fatty acids profiles in autism: A case control study. Prostaglandins, Leukotrienes and Essential fatty acids 80 (2009) 221-227
545. Williams G., King J., Cunningham M., Steohan M., Kerr B., and Hersh J.H. Fetal valproate syndrome and autism: Additional evidence of an association. Developmental Medicine and Child Neurology 43 (2001) 202-206
546. Williams J.F., and Szentivanyi A. Depression of hepatic drug-metabolizing enzyme activity by B. pertussis vaccination. European Journal of Pharmacology 43 (1977) 281-284
547. Williams P.G., and Hersh J.H. A male with fetal valproate syndrome and autism. Developmental Medicine and Child Neurology 36 (1997) 632-634
548. Williams S.J., Baird-Lambert J.A., and Farrell G.C. Inhibition of theophylline metabolism by interferon. Lancet 2 (1987) 939-941
549. Williams S.J., and Farrell G.C. Inhibition of antypyrine metabolism by interferon. British Journal of Clinical Pharmacology 22 (1986) 610-612
550. Wilson G.S. Indirect effects: Provocation disease. The hazards of immunization (1967), The Athlone Press, London, England pp. 265-280
551. Wong J.M., and Billiar T.R. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Advances in Pharmacology 34 (1995) 155-170
552. Wong J.Y., Lee E.J., and Moochhala S.M. The effects of an interferon inducer, polyriboinosinic polyribocytidylic acid on cytochrome P-450 dependent hepatic progesterone metabolism. Life Sciences 53 (1993) 1893-1901
553. Worth J. Paraoxonase polymorphisms and organophosphates. Lancet 360 (2002) 802-803
554. Wrighton S.A., and Stevens J.C. The human hepatic cytochrome P450 involved in drug metabolism. Critical Reviews in Toxicology 22 (1992) 1-21
555. Wu D., Koga T., Martin K.R., and Meydani M. Effect of vitamin E on human aortic endothelial cells production of chemokines and adhesion to monocytes. Atherosclerosis 147 (1999) 297-307
556. Xiao B.G., Mousa A., Kivisakk P., Seiger A., Bakhiet M., and Link H. Induction of beta-family chemokines mRNA in human embryonic astrocytes by inflammatory cytokines and measles virus protein. Journal of Neurocytology 27 (1998) 575-580
557. Xiong N., Ji C., Li Y., He Z., Bo H., and Zhao Y. The physical status of children with autism in China. Research in Developmental Disabilities 30 (2009) 70-76
558. Xu D.X., Wang H., Ning H., Zhao L., and Chen Y.H. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain. Journal of Pineal Research 43 (2007) 74-79
559. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., and Dehpour A.R. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Research 68 (2006) 103-113
560. Yamashita Y., Fujimoto C., Nakajima E., Isagi T., and Matshuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. Journal of Autism and Developmental Disorders 33 (2003) 455-459
561. Yamauchi K., Nakajima K., Ikeo S., Nishimura Y., Komatsu M., Aizawa T., et al. Effects of nipradiol, a nitric oxide-releasing beta-adrenoceptor blocking agent, on phosphoenolpyruvate carboxykinase gene transcription in a rat hepatoma cell line. Japanese Journal of Pharmacology 87 (2001) 83-85
562. Yang Y., Zhang W.G., Chen Y.X., Cao X.M., He A.L., Yang H.Y., et al. Positive immunoregulation of thalidomide on human peripheral blood mononuclear cell cultures. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 (2006) 1172-1177
563. Yang J., Shi D., Yang D., Song X., and Yan B. Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2. Molecular Pharmacology 72 (2007) 686-694
564. Yel L., Brown L.E., Su K., Gollapudi S., and Gupta S. Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. International Journal of Molecular Medicine 16 (2005) 971-977
565. Yorbik O., Akay C., Sayal A., Cansever A., Sohmen T., and Cavdar A.O. Zinc status in autistic children. Journal of Traced Elements and Experimental Medicine 17 (2004) 101-107
566. Yorbik O., Sayal A., Akay C., Akbiyik D.I., and Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins, Leukotrienes, and Essential Fatty Acids 67 (2002) 341-343
567. Yoshikawa T., Takano H., Naito Y., Oyamada H., Ueda S., and Kondo M. Augmentative effects of tumor necrosis factor-alpha (human, natural type) on polymorphonuclear leukocyte-derived superoxide generation induced by various stimulants. International Journal of Immunopharmacology 14 (1992) 1391-1398
568. Yoshikawa H., Kurokawa M., Ozaki N., Nara K., Atou K., Takada E., Kamochi H., and Suzuki N. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clinical and Experimental Immunology 146 (2006) 116-123
569. Young J.D., and McGwire B.S. Infliximab and reactivation of cerebral toxoplasmosis. The New England Journal of Medicine 353 (2005) 1530-1531
570. Youngner J.S., and Stinebring W.R. Comparison of interferon production in mice by bacterial endotoxin and statolon. Virology 1 (1966) 310-316
571. Zhang K., and Kaufman R.J. The unfolded protein response: A stress signaling pathway critical for health and disease. Neurology 66 (2006) S102-S109
572. Zhang Y., and Denkers E.Y. Protective role for interleukin-5 during chronic Toxoplasma gondii infection. Infection and Immunity 69 (2001) 1044-1052
573. Zimmerman A.W., Jyonouchi H., Comi A.M., Connors S.L., Milstien S., Varsou A., et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology 33 (2005) 195-201
574. Zimmermann U., Kraus T., Himmerich H., Schuld A., and Pollmächer T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. Journal of Psychiatric Research 37 (2003) 193-220
575. Zoroǧlu S.S., Armutcu F., Ozen S., Gurel A., Sivasli E., Yetkin O., et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. European Archives of Psychiatry and Clinical Neuroscience 254 (2004) 143-147
576. Zoroǧlu S.S., Yurekli M., Meram I., Sogut S., Tutkun H., Yetkin O., et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochemistry and Function 21 (2003) 55-60
577. Zucker N.L., Losh M., Bulik C.M., LaBar K.S., Piven J., and Pelphrey K.A. Anorexia nervosa and autism spectrum disorders: Guided investigation of social cognitive endophenotypes. Psychological Bulletin 133 (2007) 976-1006
578. Zucker N.L., and Losh M. Repetitive behaviours in anorexia nervosa, autism, and obsessive-compulsive personality disorder. Psychiatry 7 (2008) 183-187